Frequencies for first 10,000 rows of pt variable in reac2005q4 dataset : 'Preferred Term'-level medical | terminology describing the event | Freq. Percent Cum. ----------------------------------------+----------------------------------- ABASIA | 12 0.12 0.12 ABDOMINAL ABSCESS | 1 0.01 0.13 ABDOMINAL BRUIT | 1 0.01 0.14 ABDOMINAL DISCOMFORT | 1 0.01 0.15 ABDOMINAL DISTENSION | 8 0.08 0.23 ABDOMINAL HAEMATOMA | 1 0.01 0.24 ABDOMINAL INFECTION | 1 0.01 0.25 ABDOMINAL INJURY | 1 0.01 0.26 ABDOMINAL MASS | 1 0.01 0.27 ABDOMINAL PAIN | 42 0.42 0.69 ABDOMINAL PAIN LOWER | 1 0.01 0.70 ABDOMINAL PAIN UPPER | 23 0.23 0.93 ABDOMINAL RIGIDITY | 1 0.01 0.94 ABDOMINAL TENDERNESS | 1 0.01 0.95 ABNORMAL BEHAVIOUR | 16 0.16 1.11 ABNORMAL CLOTTING FACTOR | 1 0.01 1.12 ABNORMAL DREAMS | 5 0.05 1.17 ABNORMAL FAECES | 1 0.01 1.18 ABORTION INDUCED | 6 0.06 1.24 ABORTION MISSED | 1 0.01 1.25 ABORTION SPONTANEOUS | 9 0.09 1.34 ABSCESS DRAINAGE | 2 0.02 1.36 ABSCESS JAW | 1 0.01 1.37 ABSCESS ORAL | 3 0.03 1.40 ABSCESS SOFT TISSUE | 1 0.01 1.41 ABULIA | 1 0.01 1.42 ACCIDENT | 4 0.04 1.46 ACCIDENT AT WORK | 1 0.01 1.47 ACCIDENTAL DRUG INTAKE BY CHILD | 7 0.07 1.54 ACCIDENTAL EXPOSURE | 2 0.02 1.56 ACCIDENTAL OVERDOSE | 6 0.06 1.62 ACIDOSIS | 2 0.02 1.64 ACNE | 1 0.01 1.65 ACQUIRED IMMUNODEFICIENCY SYNDROME | 1 0.01 1.66 ACQUIRED PORPHYRIA | 1 0.01 1.67 ACTINOMYCOSIS | 2 0.02 1.69 ACTIVATED PARTIAL THROMBOPLASTIN TIME.. | 6 0.06 1.75 ACTIVATED PROTEIN C RESISTANCE | 1 0.01 1.76 ACTIVITIES OF DAILY LIVING IMPAIRED | 3 0.03 1.79 ACUTE ABDOMEN | 2 0.02 1.81 ACUTE CORONARY SYNDROME | 2 0.02 1.83 ACUTE GENERALISED EXANTHEMATOUS PUSTU.. | 1 0.01 1.84 ACUTE MYELOID LEUKAEMIA | 1 0.01 1.85 ACUTE MYOCARDIAL INFARCTION | 11 0.11 1.96 ACUTE PROMYELOCYTIC LEUKAEMIA | 1 0.01 1.97 ACUTE PSYCHOSIS | 1 0.01 1.98 ACUTE PULMONARY OEDEMA | 3 0.03 2.01 ACUTE RESPIRATORY DISTRESS SYNDROME | 6 0.06 2.07 ACUTE RESPIRATORY FAILURE | 2 0.02 2.09 ACUTE SINUSITIS | 1 0.01 2.10 ACUTE TONSILLITIS | 1 0.01 2.11 ADENOCARCINOMA | 1 0.01 2.12 ADENOVIRAL HAEMORRHAGIC CYSTITIS | 1 0.01 2.13 ADHESION | 2 0.02 2.15 ADRENAL CYST | 1 0.01 2.16 ADRENAL DISORDER | 1 0.01 2.17 ADRENAL INSUFFICIENCY | 3 0.03 2.20 ADVERSE DRUG REACTION | 1 0.01 2.21 ADVERSE EVENT | 30 0.30 2.51 AFFECTIVE DISORDER | 4 0.04 2.55 AGEUSIA | 3 0.03 2.58 AGGRESSION | 20 0.20 2.78 AGITATION | 25 0.25 3.03 AGNOSIA | 1 0.01 3.04 AGORAPHOBIA | 2 0.02 3.06 AGRANULOCYTOSIS | 4 0.04 3.10 AGRAPHIA | 1 0.01 3.11 AIRWAY COMPLICATION OF ANAESTHESIA | 1 0.01 3.12 AKATHISIA | 1 0.01 3.13 AKINESIA | 1 0.01 3.14 ALANINE AMINOTRANSFERASE INCREASED | 41 0.41 3.55 ALCOHOL POISONING | 1 0.01 3.56 ALCOHOL USE | 5 0.05 3.61 ALCOHOL WITHDRAWAL SYNDROME | 2 0.02 3.63 ALCOHOLIC | 1 0.01 3.64 ALCOHOLISM | 2 0.02 3.66 ALKALOSIS | 1 0.01 3.67 ALLERGIC GRANULOMATOUS ANGIITIS | 2 0.02 3.69 ALLERGIC SINUSITIS | 1 0.01 3.70 ALLODYNIA | 1 0.01 3.71 ALOPECIA | 11 0.11 3.82 ALVEOLAR PROTEINOSIS | 1 0.01 3.83 ALVEOLITIS | 1 0.01 3.84 AMAUROSIS FUGAX | 1 0.01 3.85 AMENORRHOEA | 1 0.01 3.86 AMMONIA INCREASED | 3 0.03 3.89 AMNESIA | 13 0.13 4.02 AMNIOTIC INFECTION SYNDROME OF BLANE | 1 0.01 4.03 AMYLOIDOSIS | 1 0.01 4.04 ANAEMIA | 45 0.45 4.49 ANAEMIA HAEMOLYTIC AUTOIMMUNE | 2 0.02 4.51 ANAEMIA MEGALOBLASTIC | 1 0.01 4.52 ANAEMIA OF MALIGNANT DISEASE | 1 0.01 4.53 ANAESTHESIA | 1 0.01 4.54 ANAL FISSURE | 1 0.01 4.55 ANAL FISTULA | 1 0.01 4.56 ANAL HAEMORRHAGE | 1 0.01 4.57 ANALGESIC DRUG LEVEL INCREASED | 2 0.02 4.59 ANAPHYLACTIC REACTION | 7 0.07 4.66 ANAPHYLACTIC SHOCK | 4 0.04 4.70 ANASTOMOTIC ULCER HAEMORRHAGE | 1 0.01 4.71 ANENCEPHALY | 1 0.01 4.72 ANEURYSM | 1 0.01 4.73 ANGER | 12 0.12 4.85 ANGINA PECTORIS | 14 0.14 4.99 ANGINA UNSTABLE | 3 0.03 5.02 ANGIOGRAM ABNORMAL | 1 0.01 5.03 ANGIONEUROTIC OEDEMA | 5 0.05 5.08 ANGIOPATHY | 5 0.05 5.13 ANGLE CLOSURE GLAUCOMA | 1 0.01 5.14 ANION GAP ABNORMAL | 1 0.01 5.15 ANION GAP INCREASED | 1 0.01 5.16 ANOREXIA | 20 0.20 5.36 ANOSMIA | 3 0.03 5.39 ANOXIC ENCEPHALOPATHY | 2 0.02 5.41 ANTI-ERYTHROPOIETIN ANTIBODY POSITIVE | 2 0.02 5.43 ANTI-HBC IGM ANTIBODY POSITIVE | 1 0.01 5.44 ANTICHOLINERGIC SYNDROME | 1 0.01 5.45 ANTICONVULSANT DRUG LEVEL INCREASED | 1 0.01 5.46 ANTICONVULSANT TOXICITY | 1 0.01 5.47 ANTIDEPRESSANT DRUG LEVEL INCREASED | 1 0.01 5.48 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY P.. | 2 0.02 5.50 ANTINUCLEAR ANTIBODY POSITIVE | 3 0.03 5.53 ANTIPHOSPHOLIPID SYNDROME | 1 0.01 5.54 ANTISOCIAL BEHAVIOUR | 1 0.01 5.55 ANURIA | 4 0.04 5.59 ANXIETY | 51 0.51 6.10 ANXIETY DISORDER | 1 0.01 6.11 AORTIC ANEURYSM | 3 0.03 6.14 AORTIC ANEURYSM REPAIR | 1 0.01 6.15 AORTIC ANEURYSM RUPTURE | 1 0.01 6.16 AORTIC DISORDER | 1 0.01 6.17 AORTIC DISSECTION | 1 0.01 6.18 AORTIC RUPTURE | 1 0.01 6.19 AORTIC THROMBOSIS | 1 0.01 6.20 AORTIC VALVE INCOMPETENCE | 2 0.02 6.22 AORTIC VALVE SCLEROSIS | 1 0.01 6.23 AORTIC VALVE STENOSIS | 2 0.02 6.25 APALLIC SYNDROME | 2 0.02 6.27 APATHY | 1 0.01 6.28 APHAGIA | 1 0.01 6.29 APHASIA | 4 0.04 6.33 APHONIA | 2 0.02 6.35 APHTHOUS STOMATITIS | 1 0.01 6.36 APLASIA | 3 0.03 6.39 APLASIA PURE RED CELL | 2 0.02 6.41 APLASTIC ANAEMIA | 3 0.03 6.44 APNOEA | 6 0.06 6.50 APPENDICECTOMY | 1 0.01 6.51 APPETITE DISORDER | 1 0.01 6.52 APPLICATION SITE DERMATITIS | 2 0.02 6.54 APPLICATION SITE DISCHARGE | 1 0.01 6.55 APPLICATION SITE ERYTHEMA | 1 0.01 6.56 APPLICATION SITE REACTION | 1 0.01 6.57 APRAXIA | 2 0.02 6.59 AREFLEXIA | 5 0.05 6.64 ARRHYTHMIA | 9 0.09 6.73 ARRHYTHMIA NEONATAL | 1 0.01 6.74 ARTERIAL DISORDER | 3 0.03 6.77 ARTERIAL HAEMORRHAGE | 1 0.01 6.78 ARTERIAL INSUFFICIENCY | 1 0.01 6.79 ARTERIAL OCCLUSIVE DISEASE | 1 0.01 6.80 ARTERIAL REPAIR | 1 0.01 6.81 ARTERIOSCLEROSIS | 8 0.08 6.89 ARTERIOSCLEROSIS CORONARY ARTERY | 4 0.04 6.93 ARTERIOSPASM CORONARY | 1 0.01 6.94 ARTERY DISSECTION | 1 0.01 6.95 ARTHRALGIA | 34 0.34 7.29 ARTHRITIS | 10 0.10 7.39 ARTHRITIS BACTERIAL | 1 0.01 7.40 ARTHRITIS INFECTIVE | 1 0.01 7.41 ARTHROPATHY | 7 0.07 7.48 ARTHROPOD BITE | 2 0.02 7.50 ASCITES | 3 0.03 7.53 ASPARTATE AMINOTRANSFERASE INCREASED | 32 0.32 7.85 ASPERGILLOMA | 1 0.01 7.86 ASPERGILLOSIS | 1 0.01 7.87 ASPHYXIA | 1 0.01 7.88 ASPIRATION | 3 0.03 7.91 ASPIRATION BONE MARROW ABNORMAL | 1 0.01 7.92 ASTERIXIS | 1 0.01 7.93 ASTHENIA | 67 0.67 8.60 ASTHMA | 9 0.09 8.69 ATELECTASIS | 3 0.03 8.72 ATELECTASIS NEONATAL | 2 0.02 8.74 ATRIAL FIBRILLATION | 26 0.26 9.00 ATRIAL FLUTTER | 2 0.02 9.02 ATRIAL SEPTAL DEFECT | 1 0.01 9.03 ATRIAL TACHYCARDIA | 1 0.01 9.04 ATRIOVENTRICULAR BLOCK | 2 0.02 9.06 ATRIOVENTRICULAR BLOCK COMPLETE | 3 0.03 9.09 ATRIOVENTRICULAR BLOCK FIRST DEGREE | 1 0.01 9.10 ATRIOVENTRICULAR BLOCK SECOND DEGREE | 1 0.01 9.11 ATROPHY | 1 0.01 9.12 ATROPHY OF TONGUE PAPILLAE | 1 0.01 9.13 ATTENTION DEFICIT/HYPERACTIVITY DISOR.. | 1 0.01 9.14 AUTOIMMUNE DISORDER | 2 0.02 9.16 AUTOIMMUNE HEPATITIS | 2 0.02 9.18 AUTOIMMUNE THROMBOCYTOPENIA | 3 0.03 9.21 AUTOIMMUNE THYROIDITIS | 1 0.01 9.22 AUTONOMIC NERVOUS SYSTEM IMBALANCE | 2 0.02 9.24 AZOOSPERMIA | 1 0.01 9.25 B-CELL LYMPHOMA | 1 0.01 9.26 BACK DISORDER | 3 0.03 9.29 BACK PAIN | 26 0.26 9.55 BACTERAEMIA | 2 0.02 9.57 BACTERIA SPUTUM IDENTIFIED | 1 0.01 9.58 BACTERIA URINE IDENTIFIED | 1 0.01 9.59 BACTERIAL CULTURE POSITIVE | 1 0.01 9.60 BACTERIAL INFECTION | 10 0.10 9.70 BACTERIAL TEST POSITIVE | 1 0.01 9.71 BACTERIURIA | 1 0.01 9.72 BACTEROIDES INFECTION | 1 0.01 9.73 BALANCE DISORDER | 11 0.11 9.84 BALLISMUS | 1 0.01 9.85 BARTTER'S SYNDROME | 1 0.01 9.86 BASAL CELL CARCINOMA | 3 0.03 9.89 BASE EXCESS INCREASED | 1 0.01 9.90 BASEDOW'S DISEASE | 1 0.01 9.91 BEDRIDDEN | 1 0.01 9.92 BENIGN BREAST NEOPLASM | 1 0.01 9.93 BENIGN PROSTATIC HYPERPLASIA | 2 0.02 9.95 BILE DUCT CANCER | 1 0.01 9.96 BILE DUCT OBSTRUCTION | 3 0.03 9.99 BILE DUCT STONE | 1 0.01 10.00 BILIARY TRACT DISORDER | 1 0.01 10.01 BILIRUBIN CONJUGATED INCREASED | 2 0.02 10.03 BIOPSY | 1 0.01 10.04 BIOPSY COLON ABNORMAL | 1 0.01 10.05 BIOPSY URETHRA ABNORMAL | 1 0.01 10.06 BIPOLAR DISORDER | 6 0.06 10.12 BIPOLAR I DISORDER | 1 0.01 10.13 BITE | 1 0.01 10.14 BLADDER CANCER | 1 0.01 10.15 BLADDER DISORDER | 1 0.01 10.16 BLADDER OPERATION | 1 0.01 10.17 BLADDER SPASM | 1 0.01 10.18 BLADDER TRABECULATION | 1 0.01 10.19 BLEEDING TIME PROLONGED | 2 0.02 10.21 BLEPHARITIS | 1 0.01 10.22 BLINDNESS | 10 0.10 10.32 BLINDNESS TRANSIENT | 1 0.01 10.33 BLINDNESS UNILATERAL | 5 0.05 10.38 BLISTER | 3 0.03 10.41 BLOOD ALBUMIN DECREASED | 4 0.04 10.45 BLOOD ALCOHOL INCREASED | 1 0.01 10.46 BLOOD ALDOSTERONE DECREASED | 1 0.01 10.47 BLOOD ALKALINE PHOSPHATASE DECREASED | 1 0.01 10.48 BLOOD ALKALINE PHOSPHATASE INCREASED | 16 0.16 10.64 BLOOD AMYLASE INCREASED | 2 0.02 10.66 BLOOD BICARBONATE DECREASED | 3 0.03 10.69 BLOOD BICARBONATE INCREASED | 1 0.01 10.70 BLOOD BILIRUBIN DECREASED | 1 0.01 10.71 BLOOD BILIRUBIN INCREASED | 19 0.19 10.90 BLOOD BILIRUBIN UNCONJUGATED INCREASED | 1 0.01 10.91 BLOOD CALCIUM DECREASED | 2 0.02 10.93 BLOOD CALCIUM INCREASED | 2 0.02 10.95 BLOOD CHLORIDE DECREASED | 2 0.02 10.97 BLOOD CHLORIDE INCREASED | 1 0.01 10.98 BLOOD CHOLESTEROL INCREASED | 13 0.13 11.11 BLOOD CHROMOGRANIN A INCREASED | 1 0.01 11.12 BLOOD COUNT ABNORMAL | 2 0.02 11.14 BLOOD CREATINE INCREASED | 1 0.01 11.15 BLOOD CREATINE PHOSPHOKINASE INCREASED | 22 0.22 11.37 BLOOD CREATININE DECREASED | 1 0.01 11.38 BLOOD CREATININE INCREASED | 33 0.33 11.71 BLOOD CULTURE POSITIVE | 5 0.05 11.76 BLOOD DISORDER | 1 0.01 11.77 BLOOD FIBRINOGEN DECREASED | 1 0.01 11.78 BLOOD GASES ABNORMAL | 1 0.01 11.79 BLOOD GLUCOSE ABNORMAL | 1 0.01 11.80 BLOOD GLUCOSE DECREASED | 5 0.05 11.85 BLOOD GLUCOSE FLUCTUATION | 2 0.02 11.87 BLOOD GLUCOSE INCREASED | 20 0.20 12.07 BLOOD IMMUNOGLOBULIN A INCREASED | 1 0.01 12.08 BLOOD IMMUNOGLOBULIN G DECREASED | 1 0.01 12.09 BLOOD IMMUNOGLOBULIN G INCREASED | 1 0.01 12.10 BLOOD IMMUNOGLOBULIN M INCREASED | 2 0.02 12.12 BLOOD IRON INCREASED | 1 0.01 12.13 BLOOD KETONE BODY INCREASED | 1 0.01 12.14 BLOOD LACTATE DEHYDROGENASE INCREASED | 11 0.11 12.25 BLOOD LACTIC ACID INCREASED | 1 0.01 12.26 BLOOD MAGNESIUM DECREASED | 3 0.03 12.29 BLOOD PARATHYROID HORMONE INCREASED | 1 0.01 12.30 BLOOD PH DECREASED | 5 0.05 12.35 BLOOD PH INCREASED | 1 0.01 12.36 BLOOD PHOSPHORUS DECREASED | 1 0.01 12.37 BLOOD PHOSPHORUS INCREASED | 1 0.01 12.38 BLOOD POTASSIUM DECREASED | 6 0.06 12.44 BLOOD POTASSIUM INCREASED | 3 0.03 12.47 BLOOD PRESSURE DECREASED | 33 0.33 12.80 BLOOD PRESSURE DIASTOLIC INCREASED | 1 0.01 12.81 BLOOD PRESSURE FLUCTUATION | 5 0.05 12.86 BLOOD PRESSURE IMMEASURABLE | 1 0.01 12.87 BLOOD PRESSURE INCREASED | 31 0.31 13.18 BLOOD PRESSURE SYSTOLIC DECREASED | 2 0.02 13.20 BLOOD PRESSURE SYSTOLIC INCREASED | 12 0.12 13.32 BLOOD PROLACTIN INCREASED | 1 0.01 13.33 BLOOD SODIUM DECREASED | 7 0.07 13.40 BLOOD SODIUM INCREASED | 2 0.02 13.42 BLOOD TESTOSTERONE DECREASED | 1 0.01 13.43 BLOOD THYROID STIMULATING HORMONE INC.. | 2 0.02 13.45 BLOOD TRIGLYCERIDES INCREASED | 4 0.04 13.49 BLOOD UREA DECREASED | 2 0.02 13.51 BLOOD UREA INCREASED | 12 0.12 13.63 BLOOD URINE PRESENT | 1 0.01 13.64 BLOOD VISCOSITY INCREASED | 1 0.01 13.65 BLUE TOE SYNDROME | 1 0.01 13.66 BLUNTED AFFECT | 1 0.01 13.67 BODY FAT DISORDER | 2 0.02 13.69 BODY HEIGHT DECREASED | 2 0.02 13.71 BODY TEMPERATURE DECREASED | 2 0.02 13.73 BODY TEMPERATURE FLUCTUATION | 1 0.01 13.74 BODY TEMPERATURE INCREASED | 9 0.09 13.83 BONE DEBRIDEMENT | 4 0.04 13.87 BONE DENSITY DECREASED | 1 0.01 13.88 BONE DEVELOPMENT ABNORMAL | 1 0.01 13.89 BONE DISORDER | 8 0.08 13.97 BONE GRAFT | 1 0.01 13.98 BONE LESION | 1 0.01 13.99 BONE MARROW DISORDER | 1 0.01 14.00 BONE MARROW FAILURE | 9 0.09 14.09 BONE MARROW MYELOGRAM ABNORMAL | 1 0.01 14.10 BONE MARROW NECROSIS | 1 0.01 14.11 BONE MARROW OEDEMA | 1 0.01 14.12 BONE MARROW TRANSPLANT | 2 0.02 14.14 BONE METABOLISM DISORDER | 1 0.01 14.15 BONE OPERATION | 1 0.01 14.16 BONE PAIN | 4 0.04 14.20 BONE SARCOMA | 1 0.01 14.21 BONE TUBERCULOSIS | 1 0.01 14.22 BOREDOM | 1 0.01 14.23 BOTULISM | 1 0.01 14.24 BOVINE TUBERCULOSIS | 1 0.01 14.25 BOWEL SOUNDS ABNORMAL | 1 0.01 14.26 BOWEN'S DISEASE | 2 0.02 14.28 BRADYCARDIA | 17 0.17 14.45 BRADYPHRENIA | 3 0.03 14.48 BRADYPNOEA | 1 0.01 14.49 BRAIN CONTUSION | 1 0.01 14.50 BRAIN DEATH | 2 0.02 14.52 BRAIN HERNIATION | 3 0.03 14.55 BRAIN OEDEMA | 4 0.04 14.59 BRAIN STEM HAEMORRHAGE | 2 0.02 14.61 BRAIN STEM SYNDROME | 1 0.01 14.62 BREAST CANCER | 7 0.07 14.69 BREAST CANCER FEMALE | 14 0.14 14.83 BREAST CANCER METASTATIC | 1 0.01 14.84 BREAST CELLULITIS | 1 0.01 14.85 BREAST DISCHARGE | 1 0.01 14.86 BREAST INFECTION | 1 0.01 14.87 BREAST MASS | 2 0.02 14.89 BREATH SOUNDS ABNORMAL | 1 0.01 14.90 BRONCHIAL CARCINOMA | 1 0.01 14.91 BRONCHITIS | 12 0.12 15.03 BRONCHITIS ACUTE | 4 0.04 15.07 BRONCHITIS CHRONIC | 1 0.01 15.08 BRONCHOALVEOLAR LAVAGE ABNORMAL | 1 0.01 15.09 BRONCHOPNEUMONIA | 3 0.03 15.12 BRONCHOPULMONARY ASPERGILLOSIS | 1 0.01 15.13 BRONCHOSPASM | 6 0.06 15.19 BRUXISM | 1 0.01 15.20 BULIMIA NERVOSA | 1 0.01 15.21 BUNDLE BRANCH BLOCK | 1 0.01 15.22 BUNDLE BRANCH BLOCK RIGHT | 7 0.07 15.29 BURKITT'S LYMPHOMA | 1 0.01 15.30 BURN INFECTION | 1 0.01 15.31 BURN OF INTERNAL ORGANS | 1 0.01 15.32 BURNING SENSATION | 7 0.07 15.39 BURNS SECOND DEGREE | 2 0.02 15.41 BURNS THIRD DEGREE | 3 0.03 15.44 BURSITIS | 2 0.02 15.46 C-REACTIVE PROTEIN INCREASED | 15 0.15 15.61 CACHEXIA | 2 0.02 15.63 CAESAREAN SECTION | 3 0.03 15.66 CALCINOSIS | 2 0.02 15.68 CALCULUS URINARY | 1 0.01 15.69 CAMPYLOBACTER INTESTINAL INFECTION | 2 0.02 15.71 CANDIDA SEPSIS | 1 0.01 15.72 CANDIDIASIS | 6 0.06 15.78 CARBON DIOXIDE DECREASED | 2 0.02 15.80 CARDIAC ARREST | 19 0.19 15.99 CARDIAC DISORDER | 34 0.34 16.33 CARDIAC FAILURE | 11 0.11 16.44 CARDIAC FAILURE ACUTE | 1 0.01 16.45 CARDIAC FAILURE CONGESTIVE | 27 0.27 16.72 CARDIAC MURMUR | 7 0.07 16.79 CARDIAC OPERATION | 1 0.01 16.80 CARDIAC PACEMAKER INSERTION | 2 0.02 16.82 CARDIAC SEPTAL DEFECT | 1 0.01 16.83 CARDIAC TAMPONADE | 2 0.02 16.85 CARDIAC VALVE DISEASE | 1 0.01 16.86 CARDIO-RESPIRATORY ARREST | 36 0.36 17.22 CARDIOGENIC SHOCK | 2 0.02 17.24 CARDIOLIPIN ANTIBODY POSITIVE | 1 0.01 17.25 CARDIOMEGALY | 6 0.06 17.31 CARDIOMYOPATHY | 6 0.06 17.37 CARDIOVASCULAR DISORDER | 65 0.65 18.02 CARDIOVERSION | 1 0.01 18.03 CAROTID ARTERY ANEURYSM | 1 0.01 18.04 CAROTID ARTERY DISEASE | 2 0.02 18.06 CAROTID ARTERY OCCLUSION | 2 0.02 18.08 CAROTID ARTERY STENOSIS | 4 0.04 18.12 CAROTID ARTERY THROMBOSIS | 1 0.01 18.13 CAROTID BRUIT | 1 0.01 18.14 CARPAL TUNNEL SYNDROME | 1 0.01 18.15 CATARACT | 5 0.05 18.20 CATARACT OPERATION | 1 0.01 18.21 CATATONIA | 1 0.01 18.22 CATHETER RELATED COMPLICATION | 2 0.02 18.24 CATHETER RELATED INFECTION | 2 0.02 18.26 CATHETER REMOVAL | 1 0.01 18.27 CATHETER SITE CELLULITIS | 1 0.01 18.28 CATHETER SITE HAEMATOMA | 2 0.02 18.30 CATHETER SITE HAEMORRHAGE | 1 0.01 18.31 CD4 LYMPHOCYTES | 1 0.01 18.32 CELLULITIS | 7 0.07 18.39 CENTRAL NERVOUS SYSTEM INFECTION | 1 0.01 18.40 CENTRAL PONTINE MYELINOLYSIS | 2 0.02 18.42 CENTRAL VENOUS CATHETERISATION | 1 0.01 18.43 CEREBELLAR ATAXIA | 1 0.01 18.44 CEREBELLAR ATROPHY | 1 0.01 18.45 CEREBELLAR SYNDROME | 2 0.02 18.47 CEREBRAL ARTERY THROMBOSIS | 1 0.01 18.48 CEREBRAL ATROPHY | 2 0.02 18.50 CEREBRAL CIRCULATORY FAILURE | 1 0.01 18.51 CEREBRAL DISORDER | 2 0.02 18.53 CEREBRAL FUNGAL INFECTION | 1 0.01 18.54 CEREBRAL HAEMATOMA | 2 0.02 18.56 CEREBRAL HAEMORRHAGE | 11 0.11 18.67 CEREBRAL INFARCTION | 8 0.08 18.75 CEREBRAL ISCHAEMIA | 4 0.04 18.79 CEREBRAL PALSY | 1 0.01 18.80 CEREBRAL THROMBOSIS | 2 0.02 18.82 CEREBRAL TOXOPLASMOSIS | 2 0.02 18.84 CEREBRAL VENOUS THROMBOSIS | 1 0.01 18.85 CEREBRAL VENTRICLE DILATATION | 2 0.02 18.87 CEREBROVASCULAR ACCIDENT | 159 1.59 20.46 CERVICAL DYSPLASIA | 1 0.01 20.47 CERVICAL VERTEBRAL FRACTURE | 2 0.02 20.49 CERVICOBRACHIAL SYNDROME | 1 0.01 20.50 CERVIX CARCINOMA | 1 0.01 20.51 CHAPPED LIPS | 1 0.01 20.52 CHEST DISCOMFORT | 14 0.14 20.66 CHEST INJURY | 1 0.01 20.67 CHEST PAIN | 53 0.53 21.20 CHEST X-RAY ABNORMAL | 3 0.03 21.23 CHILLS | 20 0.20 21.43 CHOKING | 5 0.05 21.48 CHOKING SENSATION | 1 0.01 21.49 CHOLANGITIS ACUTE | 1 0.01 21.50 CHOLANGITIS SCLEROSING | 1 0.01 21.51 CHOLECYSTITIS | 1 0.01 21.52 CHOLECYSTITIS ACUTE | 1 0.01 21.53 CHOLELITHIASIS | 9 0.09 21.62 CHOLESTASIS | 9 0.09 21.71 CHONDROMA | 1 0.01 21.72 CHONDROPATHY | 1 0.01 21.73 CHOREA | 1 0.01 21.74 CHORIOAMNIONITIS | 1 0.01 21.75 CHORIORETINOPATHY | 1 0.01 21.76 CHROMATURIA | 4 0.04 21.80 CHROMOSOME ABNORMALITY | 1 0.01 21.81 CHRONIC FATIGUE SYNDROME | 2 0.02 21.83 CHRONIC LYMPHOCYTIC LEUKAEMIA | 1 0.01 21.84 CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 14 0.14 21.98 CHRONIC SINUSITIS | 3 0.03 22.01 CIRCULATORY COLLAPSE | 6 0.06 22.07 CLAUSTROPHOBIA | 1 0.01 22.08 CLONIC CONVULSION | 2 0.02 22.10 CLONUS | 1 0.01 22.11 CLOSTRIDIAL INFECTION | 5 0.05 22.16 CLOSTRIDIUM COLITIS | 5 0.05 22.21 CLOSTRIDIUM DIFFICILE TOXIN TEST POSI.. | 1 0.01 22.22 COAGULATION FACTOR X LEVEL DECREASED | 1 0.01 22.23 COAGULATION TEST ABNORMAL | 1 0.01 22.24 COAGULOPATHY | 5 0.05 22.29 COCCYDYNIA | 1 0.01 22.30 COGNITIVE DISORDER | 6 0.06 22.36 COLD SWEAT | 3 0.03 22.39 COLECTOMY | 1 0.01 22.40 COLITIS | 5 0.05 22.45 COLITIS ISCHAEMIC | 1 0.01 22.46 COLITIS ULCERATIVE | 7 0.07 22.53 COLLAGEN DISORDER | 1 0.01 22.54 COLLAPSE OF LUNG | 2 0.02 22.56 COLON ADENOMA | 1 0.01 22.57 COLON CANCER | 2 0.02 22.59 COLON INJURY | 1 0.01 22.60 COLONIC FISTULA | 1 0.01 22.61 COLONIC POLYP | 2 0.02 22.63 COLORECTAL CANCER | 1 0.01 22.64 COLOUR BLINDNESS | 2 0.02 22.66 COLOUR VISION TESTS ABNORMAL RED-GREEN | 1 0.01 22.67 COMA | 16 0.16 22.83 COMA HEPATIC | 1 0.01 22.84 COMMUNICATION DISORDER | 3 0.03 22.87 COMPARTMENT SYNDROME | 1 0.01 22.88 COMPLETED SUICIDE | 64 0.64 23.52 COMPLEX PARTIAL SEIZURES | 1 0.01 23.53 COMPLEX REGIONAL PAIN SYNDROME | 1 0.01 23.54 COMPLICATIONS OF TRANSPLANT SURGERY | 2 0.02 23.56 COMPLICATIONS OF TRANSPLANTED KIDNEY | 3 0.03 23.59 COMPUTERISED TOMOGRAM ABNORMAL | 2 0.02 23.61 CONCOMITANT DISEASE PROGRESSION | 1 0.01 23.62 CONCUSSION | 2 0.02 23.64 CONDITION AGGRAVATED | 55 0.55 24.19 CONDUCTION DISORDER | 1 0.01 24.20 CONDYLOMA ACUMINATUM | 1 0.01 24.21 CONFUSIONAL STATE | 46 0.46 24.67 CONGENITAL EYELID MALFORMATION | 1 0.01 24.68 CONGENITAL LIMB HYPEREXTENSION | 1 0.01 24.69 CONGENITAL MUSCULOSKELETAL ANOMALY | 1 0.01 24.70 CONGENITAL NAIL DISORDER | 1 0.01 24.71 CONGENITAL PYELOCALIECTASIS | 1 0.01 24.72 CONGENITAL SCOLIOSIS | 2 0.02 24.74 CONGESTIVE CARDIOMYOPATHY | 1 0.01 24.75 CONJUNCTIVAL DEGENERATION | 1 0.01 24.76 CONJUNCTIVAL HAEMORRHAGE | 1 0.01 24.77 CONJUNCTIVAL OEDEMA | 1 0.01 24.78 CONJUNCTIVITIS | 4 0.04 24.82 CONSTIPATION | 23 0.23 25.05 CONTRAINDICATION TO MEDICAL TREATMENT | 1 0.01 25.06 CONTRALATERAL BREAST CANCER | 1 0.01 25.07 CONTUSION | 8 0.08 25.15 CONVULSION | 53 0.53 25.68 CONVULSION NEONATAL | 1 0.01 25.69 COOMBS DIRECT TEST POSITIVE | 2 0.02 25.71 COOMBS INDIRECT TEST POSITIVE | 1 0.01 25.72 COORDINATION ABNORMAL | 11 0.11 25.83 CORNEAL DYSTROPHY | 1 0.01 25.84 CORNEAL INFECTION | 1 0.01 25.85 CORONARY ARTERY DISEASE | 18 0.18 26.03 CORONARY ARTERY OCCLUSION | 5 0.05 26.08 CORONARY ARTERY PERFORATION | 1 0.01 26.09 CORONARY ARTERY STENOSIS | 3 0.03 26.12 CORONARY ARTERY SURGERY | 1 0.01 26.13 CORONARY ARTERY THROMBOSIS | 2 0.02 26.15 CORRECTIVE LENS USER | 1 0.01 26.16 COUGH | 24 0.24 26.40 CRANIAL NERVE DISORDER | 1 0.01 26.41 CRANIOSYNOSTOSIS | 1 0.01 26.42 CREATININE RENAL CLEARANCE DECREASED | 2 0.02 26.44 CROHN'S DISEASE | 7 0.07 26.51 CRYING | 10 0.10 26.61 CRYPTOGENIC ORGANIZING PNEUMONIA | 1 0.01 26.62 CSF CELL COUNT INCREASED | 1 0.01 26.63 CSF GLUCOSE DECREASED | 1 0.01 26.64 CSF PROTEIN INCREASED | 3 0.03 26.67 CSF SHUNT OPERATION | 1 0.01 26.68 CULTURE POSITIVE | 1 0.01 26.69 CULTURE TISSUE SPECIMEN POSITIVE | 1 0.01 26.70 CULTURE URINE POSITIVE | 1 0.01 26.71 CUSHING'S SYNDROME | 2 0.02 26.73 CUTANEOUS VASCULITIS | 2 0.02 26.75 CYANOPSIA | 1 0.01 26.76 CYANOSIS | 6 0.06 26.82 CYSTITIS | 5 0.05 26.87 CYSTITIS HAEMORRHAGIC | 1 0.01 26.88 CYTOLYTIC HEPATITIS | 4 0.04 26.92 CYTOMEGALOVIRUS ANTIBODY POSITIVE | 1 0.01 26.93 CYTOMEGALOVIRUS CHORIORETINITIS | 1 0.01 26.94 CYTOMEGALOVIRUS INFECTION | 4 0.04 26.98 DACRYOCYSTITIS INFECTIVE | 1 0.01 26.99 DEAFNESS | 5 0.05 27.04 DEATH | 82 0.82 27.86 DEATH OF PARENT | 1 0.01 27.87 DECREASED ACTIVITY | 2 0.02 27.89 DECREASED APPETITE | 15 0.15 28.04 DECREASED INTEREST | 3 0.03 28.07 DECUBITUS ULCER | 2 0.02 28.09 DEEP VEIN THROMBOSIS | 21 0.21 28.30 DEFORMITY THORAX | 1 0.01 28.31 DEHYDRATION | 47 0.47 28.78 DELIRIUM | 5 0.05 28.83 DELUSION | 4 0.04 28.87 DEMENTIA | 5 0.05 28.92 DENTAL CARE | 1 0.01 28.93 DENTAL NECROSIS | 1 0.01 28.94 DENTAL TREATMENT | 1 0.01 28.95 DEPENDENCE | 2 0.02 28.97 DEPRESSED LEVEL OF CONSCIOUSNESS | 23 0.23 29.20 DEPRESSED MOOD | 4 0.04 29.24 DEPRESSION | 55 0.55 29.79 DEPRESSION SUICIDAL | 2 0.02 29.81 DERMAL CYST | 1 0.01 29.82 DERMATITIS | 3 0.03 29.85 DERMATITIS ALLERGIC | 2 0.02 29.87 DERMATITIS BULLOUS | 6 0.06 29.93 DERMATITIS CONTACT | 2 0.02 29.95 DERMATITIS EXFOLIATIVE | 1 0.01 29.96 DEVICE FAILURE | 1 0.01 29.97 DEVICE RELATED INFECTION | 1 0.01 29.98 DIABETES INSIPIDUS | 1 0.01 29.99 DIABETES MELLITUS | 8 0.08 30.07 DIABETES MELLITUS INADEQUATE CONTROL | 4 0.04 30.11 DIABETES MELLITUS NON-INSULIN-DEPENDENT | 4 0.04 30.15 DIABETIC COMPLICATION | 1 0.01 30.16 DIABETIC KETOACIDOSIS | 4 0.04 30.20 DIABETIC NEPHROPATHY | 1 0.01 30.21 DIABETIC NEUROPATHY | 1 0.01 30.22 DIABETIC RETINOPATHY | 3 0.03 30.25 DIALYSIS | 7 0.07 30.32 DIAPHRAGMALGIA | 1 0.01 30.33 DIARRHOEA | 66 0.66 30.99 DIARRHOEA HAEMORRHAGIC | 5 0.05 31.04 DIFFICULTY IN WALKING | 20 0.20 31.24 DIFFUSE ALVEOLAR DAMAGE | 2 0.02 31.26 DILATATION ATRIAL | 1 0.01 31.27 DILATATION VENTRICULAR | 3 0.03 31.30 DIPLEGIA | 1 0.01 31.31 DIPLOPIA | 5 0.05 31.36 DISABILITY | 2 0.02 31.38 DISCOMFORT | 3 0.03 31.41 DISEASE PROGRESSION | 13 0.13 31.54 DISEASE RECURRENCE | 5 0.05 31.59 DISORIENTATION | 20 0.20 31.79 DISSEMINATED INTRAVASCULAR COAGULATION | 8 0.08 31.87 DISSEMINATED TUBERCULOSIS | 2 0.02 31.89 DISSOCIATION | 1 0.01 31.90 DISTURBANCE IN ATTENTION | 11 0.11 32.01 DISTURBANCE IN SOCIAL BEHAVIOUR | 2 0.02 32.03 DIVERTICULITIS | 3 0.03 32.06 DIVERTICULUM | 1 0.01 32.07 DIZZINESS | 88 0.88 32.95 DIZZINESS POSTURAL | 2 0.02 32.97 DROOLING | 1 0.01 32.98 DRUG ABUSER | 7 0.07 33.05 DRUG ADMINISTRATION ERROR | 7 0.07 33.12 DRUG DEPENDENCE | 13 0.13 33.25 DRUG DISPENSING ERROR | 3 0.03 33.28 DRUG DOSE OMISSION | 5 0.05 33.33 DRUG EFFECT DECREASED | 7 0.07 33.40 DRUG EFFECT INCREASED | 1 0.01 33.41 DRUG ERUPTION | 3 0.03 33.44 DRUG EXPOSURE DURING PREGNANCY | 35 0.35 33.79 DRUG EXPOSURE VIA BREAST MILK | 2 0.02 33.81 DRUG HYPERSENSITIVITY | 9 0.09 33.90 DRUG INEFFECTIVE | 58 0.58 34.48 DRUG INEFFECTIVE FOR UNAPPROVED INDIC.. | 2 0.02 34.50 DRUG INTERACTION | 36 0.36 34.86 DRUG INTOLERANCE | 2 0.02 34.88 DRUG LEVEL BELOW THERAPEUTIC | 1 0.01 34.89 DRUG LEVEL DECREASED | 7 0.07 34.96 DRUG LEVEL FLUCTUATING | 2 0.02 34.98 DRUG LEVEL INCREASED | 4 0.04 35.02 DRUG PRESCRIBING ERROR | 1 0.01 35.03 DRUG RASH WITH EOSINOPHILIA AND SYSTE.. | 2 0.02 35.05 DRUG RESISTANCE | 2 0.02 35.07 DRUG SCREEN POSITIVE | 3 0.03 35.10 DRUG TOLERANCE | 1 0.01 35.11 DRUG TOLERANCE DECREASED | 1 0.01 35.12 DRUG TOLERANCE INCREASED | 1 0.01 35.13 DRUG TOXICITY | 8 0.08 35.21 DRUG WITHDRAWAL SYNDROME | 11 0.11 35.32 DRUG WITHDRAWAL SYNDROME NEONATAL | 2 0.02 35.34 DRY EYE | 1 0.01 35.35 DRY MOUTH | 16 0.16 35.51 DRY SKIN | 7 0.07 35.58 DRY THROAT | 1 0.01 35.59 DUCTUS ARTERIOSUS STENOSIS FOETAL | 1 0.01 35.60 DUODENAL ULCER | 3 0.03 35.63 DUODENAL ULCER PERFORATION | 3 0.03 35.66 DYSAESTHESIA | 1 0.01 35.67 DYSARTHRIA | 12 0.12 35.79 DYSGEUSIA | 14 0.14 35.93 DYSGLOBULINAEMIA | 1 0.01 35.94 DYSGRAPHIA | 2 0.02 35.96 DYSKINESIA | 7 0.07 36.03 DYSLEXIA | 1 0.01 36.04 DYSLIPIDAEMIA | 1 0.01 36.05 DYSMENORRHOEA | 1 0.01 36.06 DYSPEPSIA | 10 0.10 36.16 DYSPHAGIA | 20 0.20 36.36 DYSPHEMIA | 3 0.03 36.39 DYSPHONIA | 5 0.05 36.44 DYSPHORIA | 2 0.02 36.46 DYSPNOEA | 87 0.87 37.33 DYSPNOEA EXACERBATED | 4 0.04 37.37 DYSPNOEA EXERTIONAL | 8 0.08 37.45 DYSSTASIA | 4 0.04 37.49 DYSTONIA | 2 0.02 37.51 DYSURIA | 8 0.08 37.59 EAR DISCOMFORT | 3 0.03 37.62 EAR HAEMORRHAGE | 1 0.01 37.63 EAR INFECTION | 2 0.02 37.65 EAR NEOPLASM | 1 0.01 37.66 EAR PAIN | 6 0.06 37.72 EATING DISORDER | 6 0.06 37.78 ECCHYMOSIS | 4 0.04 37.82 ECHOGRAPHY ABNORMAL | 1 0.01 37.83 ECONOMIC PROBLEM | 4 0.04 37.87 ECZEMA | 4 0.04 37.91 ECZEMA INFECTED | 1 0.01 37.92 EDUCATIONAL PROBLEM | 1 0.01 37.93 EFFUSION | 1 0.01 37.94 EHLERS-DANLOS SYNDROME | 1 0.01 37.95 EJACULATION DELAYED | 1 0.01 37.96 EJACULATION DISORDER | 1 0.01 37.97 EJECTION FRACTION DECREASED | 2 0.02 37.99 ELECTRIC SHOCK | 1 0.01 38.00 ELECTROCARDIOGRAM PR SHORTENED | 1 0.01 38.01 ELECTROCARDIOGRAM Q WAVE ABNORMAL | 1 0.01 38.02 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED | 1 0.01 38.03 ELECTROCARDIOGRAM QT CORRECTED INTERV.. | 5 0.05 38.08 ELECTROCARDIOGRAM QT PROLONGED | 5 0.05 38.13 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION | 1 0.01 38.14 ELECTROCARDIOGRAM ST SEGMENT ELEVATION | 2 0.02 38.16 ELECTROCARDIOGRAM T WAVE INVERSION | 4 0.04 38.20 ELECTROENCEPHALOGRAM ABNORMAL | 2 0.02 38.22 ELECTROLYTE IMBALANCE | 6 0.06 38.28 ELECTROMECHANICAL DISSOCIATION | 2 0.02 38.30 EMBOLIC STROKE | 1 0.01 38.31 EMBOLISM | 1 0.01 38.32 EMOTIONAL DISORDER | 3 0.03 38.35 EMOTIONAL DISTRESS | 10 0.10 38.45 EMPHYSEMA | 5 0.05 38.50 ENAMEL ANOMALY | 1 0.01 38.51 ENANTHEMA | 1 0.01 38.52 ENCEPHALITIS | 1 0.01 38.53 ENCEPHALITIS VIRAL | 2 0.02 38.55 ENCEPHALOPATHY | 8 0.08 38.63 ENDOCARDITIS | 1 0.01 38.64 ENDODONTIC PROCEDURE | 1 0.01 38.65 ENDOMETRIAL CANCER | 1 0.01 38.66 ENDOMETRIAL CANCER STAGE I | 1 0.01 38.67 ENTERITIS | 2 0.02 38.69 ENTEROCOLITIS | 1 0.01 38.70 ENURESIS | 1 0.01 38.71 ENZYME ABNORMALITY | 1 0.01 38.72 EOSINOPHIL COUNT INCREASED | 3 0.03 38.75 EOSINOPHILIA | 6 0.06 38.81 EOSINOPHILIC PNEUMONIA | 2 0.02 38.83 EPILEPSY | 8 0.08 38.91 EPISTAXIS | 6 0.06 38.97 EPSTEIN-BARR VIRUS INFECTION | 1 0.01 38.98 EPSTEIN-BARR VIRUS TEST POSITIVE | 1 0.01 38.99 ERECTILE DYSFUNCTION | 8 0.08 39.07 ERECTION INCREASED | 2 0.02 39.09 ERUCTATION | 1 0.01 39.10 ERYSIPELAS | 3 0.03 39.13 ERYTHEMA | 22 0.22 39.35 ERYTHEMA MULTIFORME | 2 0.02 39.37 ERYTHEMA NODOSUM | 3 0.03 39.40 ERYTHRODERMIC PSORIASIS | 2 0.02 39.42 ESCHERICHIA INFECTION | 3 0.03 39.45 ESCHERICHIA SEPSIS | 1 0.01 39.46 ESCHERICHIA URINARY TRACT INFECTION | 1 0.01 39.47 EUPHORIC MOOD | 2 0.02 39.49 EUSTACHIAN TUBE DYSFUNCTION | 1 0.01 39.50 EVAN'S SYNDROME | 3 0.03 39.53 EXCESSIVE GRANULATION TISSUE | 9 0.09 39.62 EXCITABILITY | 1 0.01 39.63 EXCORIATION | 2 0.02 39.65 EXERCISE TOLERANCE DECREASED | 1 0.01 39.66 EXFOLIATIVE RASH | 3 0.03 39.69 EXOPHTHALMOS | 1 0.01 39.70 EXOSTOSIS | 2 0.02 39.72 EXTENSOR PLANTAR RESPONSE | 1 0.01 39.73 EXTRADURAL ABSCESS | 2 0.02 39.75 EXTRAMEDULLARY HAEMOPOIESIS | 1 0.01 39.76 EXTRAOCULAR MUSCLE PARESIS | 1 0.01 39.77 EXTRAPYRAMIDAL DISORDER | 1 0.01 39.78 EXTRASYSTOLES | 6 0.06 39.84 EXTRAVASATION | 1 0.01 39.85 EXTREMITY NECROSIS | 1 0.01 39.86 EYE BURNS | 1 0.01 39.87 EYE DISORDER | 6 0.06 39.93 EYE EXCISION | 2 0.02 39.95 EYE INFECTION BACTERIAL | 1 0.01 39.96 EYE INFLAMMATION | 1 0.01 39.97 EYE IRRITATION | 3 0.03 40.00 EYE MOVEMENT DISORDER | 2 0.02 40.02 EYE OEDEMA | 1 0.01 40.03 EYE PAIN | 7 0.07 40.10 EYE PRURITUS | 1 0.01 40.11 EYE ROLLING | 1 0.01 40.12 EYE SWELLING | 3 0.03 40.15 EYELID FUNCTION DISORDER | 2 0.02 40.17 EYELID OEDEMA | 1 0.01 40.18 EYELID PTOSIS | 1 0.01 40.19 FACE INJURY | 1 0.01 40.20 FACE OEDEMA | 6 0.06 40.26 FACET JOINT SYNDROME | 1 0.01 40.27 FACIAL BONES FRACTURE | 2 0.02 40.29 FACIAL DYSMORPHISM | 1 0.01 40.30 FACIAL HEMIATROPHY | 1 0.01 40.31 FACIAL PAIN | 3 0.03 40.34 FACIAL PALSY | 6 0.06 40.40 FACIAL PARESIS | 2 0.02 40.42 FACTOR II DEFICIENCY | 1 0.01 40.43 FACTOR V LEIDEN MUTATION | 1 0.01 40.44 FAECAL INCONTINENCE | 1 0.01 40.45 FAECAL VOLUME INCREASED | 1 0.01 40.46 FAECES DISCOLOURED | 4 0.04 40.50 FAILURE TO ANASTOMOSE | 1 0.01 40.51 FALL | 50 0.50 41.01 FALLOT'S TETRALOGY | 1 0.01 41.02 FAMILY STRESS | 1 0.01 41.03 FANCONI SYNDROME | 1 0.01 41.04 FASCIITIS | 2 0.02 41.06 FAT TISSUE INCREASED | 1 0.01 41.07 FATIGUE | 59 0.59 41.66 FEAR | 5 0.05 41.71 FEBRILE BONE MARROW APLASIA | 1 0.01 41.72 FEBRILE INFECTION | 1 0.01 41.73 FEBRILE NEUTROPENIA | 12 0.12 41.85 FEEDING DISORDER NEONATAL | 1 0.01 41.86 FEEDING TUBE COMPLICATION | 1 0.01 41.87 FEELING ABNORMAL | 26 0.26 42.13 FEELING COLD | 7 0.07 42.20 FEELING DRUNK | 1 0.01 42.21 FEELING HOT | 5 0.05 42.26 FEELING HOT AND COLD | 1 0.01 42.27 FEELING JITTERY | 2 0.02 42.29 FEELING OF DESPAIR | 1 0.01 42.30 FEMALE GENITAL TRACT FISTULA | 1 0.01 42.31 FEMORAL ARTERIAL STENOSIS | 1 0.01 42.32 FEMORAL BRUIT | 1 0.01 42.33 FEMORAL NECK FRACTURE | 1 0.01 42.34 FEMUR FRACTURE | 3 0.03 42.37 FIBRIN D DIMER INCREASED | 2 0.02 42.39 FIBROMYALGIA | 2 0.02 42.41 FIBROSIS | 1 0.01 42.42 FINGER AMPUTATION | 1 0.01 42.43 FISTULA | 2 0.02 42.45 FLANK PAIN | 3 0.03 42.48 FLATULENCE | 5 0.05 42.53 FLUID INTAKE REDUCED | 3 0.03 42.56 FLUID RETENTION | 6 0.06 42.62 FLUSHING | 7 0.07 42.69 FOAMING AT MOUTH | 1 0.01 42.70 FOCAL GLOMERULOSCLEROSIS | 1 0.01 42.71 FOETAL GROWTH RETARDATION | 1 0.01 42.72 FOETAL HEART RATE ABNORMAL | 2 0.02 42.74 FOLATE DEFICIENCY | 1 0.01 42.75 FOOD ALLERGY | 1 0.01 42.76 FOOT FRACTURE | 3 0.03 42.79 FOOT OPERATION | 1 0.01 42.80 FOREIGN BODY IN EYE | 1 0.01 42.81 FOREIGN BODY SENSATION IN EYES | 1 0.01 42.82 FOREIGN BODY TRAUMA | 3 0.03 42.85 FORMICATION | 1 0.01 42.86 FRACTURE | 5 0.05 42.91 FREE THYROXINE INDEX INCREASED | 1 0.01 42.92 FUNGAL ENDOCARDITIS | 1 0.01 42.93 FUNGAL INFECTION | 13 0.13 43.06 FUNGAL SKIN INFECTION | 1 0.01 43.07 FURUNCLE | 4 0.04 43.11 GAIT DISTURBANCE | 6 0.06 43.17 GALACTOCELE | 1 0.01 43.18 GALLBLADDER DISORDER | 4 0.04 43.22 GALLBLADDER OPERATION | 2 0.02 43.24 GALLBLADDER PERFORATION | 1 0.01 43.25 GALLBLADDER POLYP | 2 0.02 43.27 GAMMA-GLUTAMYLTRANSFERASE DECREASED | 1 0.01 43.28 GAMMA-GLUTAMYLTRANSFERASE INCREASED | 12 0.12 43.40 GAS GANGRENE | 1 0.01 43.41 GASTRIC ADENOMA | 1 0.01 43.42 GASTRIC DISORDER | 9 0.09 43.51 GASTRIC HAEMORRHAGE | 3 0.03 43.54 GASTRIC LAVAGE | 1 0.01 43.55 GASTRIC PERFORATION | 1 0.01 43.56 GASTRIC ULCER | 7 0.07 43.63 GASTRITIS | 5 0.05 43.68 GASTRITIS EROSIVE | 1 0.01 43.69 GASTRITIS HAEMORRHAGIC | 2 0.02 43.71 GASTROENTERITIS | 5 0.05 43.76 GASTROENTERITIS VIRAL | 2 0.02 43.78 GASTROINTESTINAL CANDIDIASIS | 1 0.01 43.79 GASTROINTESTINAL CARCINOMA | 1 0.01 43.80 GASTROINTESTINAL DISORDER | 12 0.12 43.92 GASTROINTESTINAL HAEMORRHAGE | 12 0.12 44.04 GASTROINTESTINAL HYPOMOTILITY | 1 0.01 44.05 GASTROINTESTINAL INFECTION | 2 0.02 44.07 GASTROINTESTINAL INFLAMMATION | 1 0.01 44.08 GASTROINTESTINAL INJURY | 1 0.01 44.09 GASTROINTESTINAL NEOPLASM | 1 0.01 44.10 GASTROINTESTINAL PERFORATION | 1 0.01 44.11 GASTROINTESTINAL ULCER HAEMORRHAGE | 1 0.01 44.12 GASTROOESOPHAGEAL REFLUX DISEASE | 8 0.08 44.20 GAZE PALSY | 3 0.03 44.23 GENERAL ANAESTHESIA | 1 0.01 44.24 GENERAL PHYSICAL CONDITION ABNORMAL | 1 0.01 44.25 GENERAL PHYSICAL HEALTH DETERIORATION | 23 0.23 44.48 GENERALISED ANXIETY DISORDER | 1 0.01 44.49 GENERALISED ERYTHEMA | 1 0.01 44.50 GENERALISED OEDEMA | 6 0.06 44.56 GENITAL DISCHARGE | 1 0.01 44.57 GENITAL HAEMORRHAGE | 1 0.01 44.58 GENITAL PRURITUS FEMALE | 1 0.01 44.59 GESTATIONAL DIABETES | 1 0.01 44.60 GINGIVAL BLEEDING | 6 0.06 44.66 GINGIVAL DISORDER | 1 0.01 44.67 GINGIVAL EROSION | 2 0.02 44.69 GINGIVAL INFECTION | 2 0.02 44.71 GINGIVAL SWELLING | 6 0.06 44.77 GINGIVITIS | 1 0.01 44.78 GLASGOW COMA SCALE ABNORMAL | 1 0.01 44.79 GLAUCOMA | 6 0.06 44.85 GLIOBLASTOMA MULTIFORME | 1 0.01 44.86 GLIOSIS | 1 0.01 44.87 GLOBAL AMNESIA | 1 0.01 44.88 GLOMERULONEPHRITIS | 2 0.02 44.90 GLOMERULONEPHRITIS MEMBRANOUS | 2 0.02 44.92 GLOMERULOSCLEROSIS | 1 0.01 44.93 GLOSSITIS | 1 0.01 44.94 GLOSSODYNIA | 5 0.05 44.99 GLOSSOPHARYNGEAL NERVE PARALYSIS | 1 0.01 45.00 GLUCOSE URINE | 1 0.01 45.01 GLUCOSE URINE PRESENT | 2 0.02 45.03 GLUTAMATE DEHYDROGENASE INCREASED | 1 0.01 45.04 GLYCOSURIA | 1 0.01 45.05 GLYCOSYLATED HAEMOGLOBIN INCREASED | 2 0.02 45.07 GOUT | 2 0.02 45.09 GRAFT COMPLICATION | 3 0.03 45.12 GRAFT INFECTION | 1 0.01 45.13 GRAFT VERSUS HOST DISEASE | 4 0.04 45.17 GRAND MAL CONVULSION | 6 0.06 45.23 GRANULOCYTE COUNT DECREASED | 3 0.03 45.26 GROIN PAIN | 2 0.02 45.28 GUILLAIN-BARRE SYNDROME | 3 0.03 45.31 GUN SHOT WOUND | 4 0.04 45.35 HAEMANGIOMA OF LIVER | 1 0.01 45.36 HAEMATEMESIS | 13 0.13 45.49 HAEMATOCHEZIA | 9 0.09 45.58 HAEMATOCRIT DECREASED | 18 0.18 45.76 HAEMATOMA | 6 0.06 45.82 HAEMATOTOXICITY | 2 0.02 45.84 HAEMATURIA | 10 0.10 45.94 HAEMOCHROMATOSIS | 1 0.01 45.95 HAEMODIALYSIS | 12 0.12 46.07 HAEMODYNAMIC INSTABILITY | 2 0.02 46.09 HAEMOGLOBIN DECREASED | 45 0.45 46.54 HAEMOLYSIS | 3 0.03 46.57 HAEMOLYTIC ANAEMIA | 2 0.02 46.59 HAEMOLYTIC URAEMIC SYNDROME | 2 0.02 46.61 HAEMOPTYSIS | 8 0.08 46.69 HAEMORRHAGE | 24 0.24 46.93 HAEMORRHAGE INTRACRANIAL | 2 0.02 46.95 HAEMORRHAGE SUBCUTANEOUS | 3 0.03 46.98 HAEMORRHAGE URINARY TRACT | 1 0.01 46.99 HAEMORRHAGIC DIATHESIS | 2 0.02 47.01 HAEMORRHAGIC STROKE | 1 0.01 47.02 HAEMORRHOIDAL HAEMORRHAGE | 1 0.01 47.03 HAEMORRHOIDS | 4 0.04 47.07 HAIR COLOUR CHANGES | 1 0.01 47.08 HAIR DISORDER | 2 0.02 47.10 HAIR GROWTH ABNORMAL | 2 0.02 47.12 HAIR METAL TEST ABNORMAL | 1 0.01 47.13 HALLUCINATION | 10 0.10 47.23 HALLUCINATION, AUDITORY | 3 0.03 47.26 HALLUCINATION, VISUAL | 4 0.04 47.30 HALLUCINATIONS, MIXED | 1 0.01 47.31 HAPTOGLOBIN DECREASED | 1 0.01 47.32 HEAD DISCOMFORT | 1 0.01 47.33 HEAD INJURY | 5 0.05 47.38 HEADACHE | 56 0.56 47.94 HEART DISEASE CONGENITAL | 1 0.01 47.95 HEART INJURY | 3 0.03 47.98 HEART RATE DECREASED | 5 0.05 48.03 HEART RATE INCREASED | 24 0.24 48.27 HEART RATE IRREGULAR | 6 0.06 48.33 HEART TRANSPLANT | 1 0.01 48.34 HEART TRANSPLANT REJECTION | 1 0.01 48.35 HELICOBACTER GASTRITIS | 1 0.01 48.36 HELICOBACTER INFECTION | 1 0.01 48.37 HEMIANOPIA HOMONYMOUS | 1 0.01 48.38 HEMIPARESIS | 1 0.01 48.39 HEMIPLEGIA | 2 0.02 48.41 HENOCH-SCHONLEIN PURPURA | 1 0.01 48.42 HEPARIN-INDUCED THROMBOCYTOPENIA | 5 0.05 48.47 HEPATIC CIRRHOSIS | 5 0.05 48.52 HEPATIC CYST | 1 0.01 48.53 HEPATIC ENCEPHALOPATHY | 1 0.01 48.54 HEPATIC ENZYME ABNORMAL | 2 0.02 48.56 HEPATIC ENZYME INCREASED | 8 0.08 48.64 HEPATIC FAILURE | 15 0.15 48.79 HEPATIC FUNCTION ABNORMAL | 17 0.17 48.96 HEPATIC NECROSIS | 1 0.01 48.97 HEPATIC NEOPLASM | 1 0.01 48.98 HEPATIC NEOPLASM MALIGNANT | 4 0.04 49.02 HEPATIC STEATOSIS | 2 0.02 49.04 HEPATIC TRAUMA | 1 0.01 49.05 HEPATITIS | 6 0.06 49.11 HEPATITIS ACUTE | 3 0.03 49.14 HEPATITIS ALCOHOLIC | 1 0.01 49.15 HEPATITIS B | 2 0.02 49.17 HEPATITIS B CORE ANTIGEN POSITIVE | 1 0.01 49.18 HEPATITIS B E ANTIGEN POSITIVE | 1 0.01 49.19 HEPATITIS B SURFACE ANTIGEN POSITIVE | 3 0.03 49.22 HEPATITIS C | 5 0.05 49.27 HEPATITIS CHOLESTATIC | 4 0.04 49.31 HEPATITIS TOXIC | 3 0.03 49.34 HEPATITIS VIRAL | 1 0.01 49.35 HEPATOCELLULAR DAMAGE | 7 0.07 49.42 HEPATOMEGALY | 4 0.04 49.46 HEPATOSPLENIC CANDIDIASIS | 1 0.01 49.47 HEPATOSPLENOMEGALY | 1 0.01 49.48 HEPATOTOXICITY | 4 0.04 49.52 HERNIA | 5 0.05 49.57 HERNIA REPAIR | 2 0.02 49.59 HERPES SIMPLEX | 2 0.02 49.61 HERPES ZOSTER | 5 0.05 49.66 HERPETIC STOMATITIS | 1 0.01 49.67 HIATUS HERNIA | 7 0.07 49.74 HICCUPS | 1 0.01 49.75 HILAR LYMPHADENOPATHY | 1 0.01 49.76 HIP FRACTURE | 2 0.02 49.78 HISTIOCYTOSIS HAEMATOPHAGIC | 1 0.01 49.79 HIV INFECTION | 1 0.01 49.80 HODGKIN'S DISEASE | 1 0.01 49.81 HOMELESS | 1 0.01 49.82 HOMICIDAL IDEATION | 3 0.03 49.85 HOMICIDE | 2 0.02 49.87 HORMONE LEVEL ABNORMAL | 1 0.01 49.88 HOSPITALISATION | 1 0.01 49.89 HOSTILITY | 2 0.02 49.91 HOT FLUSH | 11 0.11 50.02 HUNGER | 2 0.02 50.04 HYDROCEPHALUS | 5 0.05 50.09 HYDRONEPHROSIS | 2 0.02 50.11 HYPERACUSIS | 1 0.01 50.12 HYPERAESTHESIA | 3 0.03 50.15 HYPERAMMONAEMIA | 1 0.01 50.16 HYPERBARIC OXYGEN THERAPY | 1 0.01 50.17 HYPERBILIRUBINAEMIA | 1 0.01 50.18 HYPERCALCAEMIA | 2 0.02 50.20 HYPERCALCIURIA | 1 0.01 50.21 HYPERCAPNIA | 3 0.03 50.24 HYPERCHOLESTEROLAEMIA | 2 0.02 50.26 HYPERCOAGULATION | 1 0.01 50.27 HYPEREOSINOPHILIC SYNDROME | 1 0.01 50.28 HYPERGAMMAGLOBULINAEMIA | 2 0.02 50.30 HYPERGASTRINAEMIA | 1 0.01 50.31 HYPERGLYCAEMIA | 9 0.09 50.40 HYPERHIDROSIS | 27 0.27 50.67 HYPERKALAEMIA | 10 0.10 50.77 HYPERLACTACIDAEMIA | 1 0.01 50.78 HYPERLIPIDAEMIA | 10 0.10 50.88 HYPERPARATHYROIDISM | 1 0.01 50.89 HYPERREFLEXIA | 3 0.03 50.92 HYPERSENSITIVITY | 19 0.19 51.11 HYPERSOMNIA | 4 0.04 51.15 HYPERSPLENISM | 2 0.02 51.17 HYPERTENSION | 38 0.38 51.55 HYPERTENSIVE CRISIS | 2 0.02 51.57 HYPERTENSIVE ENCEPHALOPATHY | 1 0.01 51.58 HYPERTENSIVE HEART DISEASE | 1 0.01 51.59 HYPERTHERMIA | 2 0.02 51.61 HYPERTHERMIA MALIGNANT | 1 0.01 51.62 HYPERTHYROIDISM | 1 0.01 51.63 HYPERTONIA | 2 0.02 51.65 HYPERTONIA NEONATAL | 1 0.01 51.66 HYPERTONIC BLADDER | 3 0.03 51.69 HYPERTRIGLYCERIDAEMIA | 1 0.01 51.70 HYPERTROPHIC CARDIOMYOPATHY | 1 0.01 51.71 HYPERTROPHY OF TONGUE PAPILLAE | 1 0.01 51.72 HYPERURICAEMIA | 1 0.01 51.73 HYPERVENTILATION | 2 0.02 51.75 HYPNAGOGIC HALLUCINATION | 1 0.01 51.76 HYPOACUSIS | 4 0.04 51.80 HYPOAESTHESIA | 16 0.16 51.96 HYPOAESTHESIA ORAL | 4 0.04 52.00 HYPOALBUMINAEMIA | 2 0.02 52.02 HYPOALDOSTERONISM | 1 0.01 52.03 HYPOCALCAEMIA | 2 0.02 52.05 HYPOCHLORAEMIA | 1 0.01 52.06 HYPOCHONDRIASIS | 1 0.01 52.07 HYPOGAMMAGLOBULINAEMIA | 1 0.01 52.08 HYPOGLYCAEMIA | 17 0.17 52.25 HYPOGLYCAEMIC COMA | 1 0.01 52.26 HYPOGLYCAEMIC ENCEPHALOPATHY | 2 0.02 52.28 HYPOGONADISM | 1 0.01 52.29 HYPOKALAEMIA | 16 0.16 52.45 HYPOKINESIA | 2 0.02 52.47 HYPOMAGNESAEMIA | 3 0.03 52.50 HYPOMANIA | 2 0.02 52.52 HYPONATRAEMIA | 13 0.13 52.65 HYPOPLASTIC ANAEMIA | 1 0.01 52.66 HYPOPROTEINAEMIA | 2 0.02 52.68 HYPOREFLEXIA | 3 0.03 52.71 HYPOTENSION | 39 0.39 53.10 HYPOTHERMIA | 2 0.02 53.12 HYPOTHYROIDISM | 3 0.03 53.15 HYPOTONIA | 4 0.04 53.19 HYPOTRICHOSIS | 1 0.01 53.20 HYPOVENTILATION | 2 0.02 53.22 HYPOVOLAEMIA | 3 0.03 53.25 HYPOXIA | 12 0.12 53.37 HYPOXIC ENCEPHALOPATHY | 1 0.01 53.38 HYSTERECTOMY | 2 0.02 53.40 IATROGENIC INJURY | 6 0.06 53.46 IDIOPATHIC THROMBOCYTOPENIC PURPURA | 2 0.02 53.48 ILEITIS | 1 0.01 53.49 ILEUS | 7 0.07 53.56 ILEUS PARALYTIC | 2 0.02 53.58 ILIAC ARTERY THROMBOSIS | 1 0.01 53.59 ILL-DEFINED DISORDER | 8 0.08 53.67 IMMOBILE | 5 0.05 53.72 IMMUNE RECONSTITUTION SYNDROME | 2 0.02 53.74 IMMUNE SYSTEM DISORDER | 3 0.03 53.77 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED | 2 0.02 53.79 IMMUNOSUPPRESSION | 2 0.02 53.81 IMPAIRED DRIVING ABILITY | 5 0.05 53.86 IMPAIRED GASTRIC EMPTYING | 2 0.02 53.88 IMPAIRED HEALING | 7 0.07 53.95 IMPAIRED WORK ABILITY | 6 0.06 54.01 IMPATIENCE | 1 0.01 54.02 IMPULSIVE BEHAVIOUR | 1 0.01 54.03 INADEQUATE ANALGESIA | 4 0.04 54.07 INADEQUATE DIET | 2 0.02 54.09 INAPPROPRIATE ANTIDIURETIC HORMONE SE.. | 5 0.05 54.14 INAPPROPRIATE SCHEDULE OF DRUG ADMINI.. | 2 0.02 54.16 INCISION SITE COMPLICATION | 2 0.02 54.18 INCOHERENT | 5 0.05 54.23 INCONTINENCE | 1 0.01 54.24 INCORRECT DOSE ADMINISTERED | 10 0.10 54.34 INCORRECT DRUG ADMINISTRATION DURATION | 1 0.01 54.35 INCREASED APPETITE | 2 0.02 54.37 INCREASED TENDENCY TO BRUISE | 1 0.01 54.38 INFANTILE APNOEIC ATTACK | 1 0.01 54.39 INFARCTION | 1 0.01 54.40 INFECTED CYST | 1 0.01 54.41 INFECTION | 16 0.16 54.57 INFECTIOUS MONONUCLEOSIS | 1 0.01 54.58 INFLAMMATION | 6 0.06 54.64 INFLAMMATORY BOWEL DISEASE | 5 0.05 54.69 INFLUENZA | 5 0.05 54.74 INFLUENZA LIKE ILLNESS | 9 0.09 54.83 INFUSION RELATED REACTION | 17 0.17 55.00 INFUSION SITE ERYTHEMA | 1 0.01 55.01 INFUSION SITE REACTION | 1 0.01 55.02 INFUSION SITE SWELLING | 1 0.01 55.03 INGUINAL HERNIA | 1 0.01 55.04 INHALATION THERAPY | 1 0.01 55.05 INJECTION SITE ATROPHY | 1 0.01 55.06 INJECTION SITE CYST | 1 0.01 55.07 INJECTION SITE ERYTHEMA | 2 0.02 55.09 INJECTION SITE EXTRAVASATION | 1 0.01 55.10 INJECTION SITE HAEMORRHAGE | 3 0.03 55.13 INJECTION SITE OEDEMA | 1 0.01 55.14 INJECTION SITE PRURITUS | 1 0.01 55.15 INJECTION SITE REACTION | 1 0.01 55.16 INJECTION SITE WARMTH | 1 0.01 55.17 INJURY | 41 0.41 55.58 INJURY ASPHYXIATION | 1 0.01 55.59 INSOMNIA | 31 0.31 55.90 INTENTIONAL DRUG MISUSE | 39 0.39 56.29 INTENTIONAL SELF-INJURY | 4 0.04 56.33 INTERCAPILLARY GLOMERULOSCLEROSIS | 1 0.01 56.34 INTERCEPTED MEDICATION ERROR | 1 0.01 56.35 INTERMITTENT CLAUDICATION | 1 0.01 56.36 INTERNAL INJURY | 2 0.02 56.38 INTERNATIONAL NORMALISED RATIO DECREA.. | 3 0.03 56.41 INTERNATIONAL NORMALISED RATIO INCREA.. | 21 0.21 56.62 INTERSTITIAL LUNG DISEASE | 19 0.19 56.81 INTERVERTEBRAL DISC DEGENERATION | 2 0.02 56.83 INTERVERTEBRAL DISC DISORDER | 3 0.03 56.86 INTERVERTEBRAL DISC OPERATION | 1 0.01 56.87 INTERVERTEBRAL DISC PROTRUSION | 5 0.05 56.92 INTESTINAL ATRESIA | 1 0.01 56.93 INTESTINAL FUNCTIONAL DISORDER | 1 0.01 56.94 INTESTINAL HAEMORRHAGE | 5 0.05 56.99 INTESTINAL INFARCTION | 1 0.01 57.00 INTESTINAL ISCHAEMIA | 1 0.01 57.01 INTESTINAL MUCOSAL HYPERTROPHY | 1 0.01 57.02 INTESTINAL OBSTRUCTION | 5 0.05 57.07 INTRA-UTERINE DEATH | 1 0.01 57.08 INTRACARDIAC THROMBUS | 1 0.01 57.09 INTRACRANIAL ANEURYSM | 3 0.03 57.12 INTRACRANIAL VENOUS SINUS THROMBOSIS | 1 0.01 57.13 INTRAOCULAR PRESSURE INCREASED | 3 0.03 57.16 INTUBATION | 1 0.01 57.17 IRIDOCELE | 1 0.01 57.18 IRIDOCYCLITIS | 1 0.01 57.19 IRIS ATROPHY | 1 0.01 57.20 IRIS DISORDER | 13 0.13 57.33 IRON DEFICIENCY ANAEMIA | 2 0.02 57.35 IRON METABOLISM DISORDER | 1 0.01 57.36 IRRITABILITY | 13 0.13 57.49 IRRITABLE BOWEL SYNDROME | 5 0.05 57.54 ISCHAEMIA | 2 0.02 57.56 ISCHAEMIC CARDIOMYOPATHY | 1 0.01 57.57 ISCHAEMIC STROKE | 16 0.16 57.73 JAUNDICE | 20 0.20 57.93 JAUNDICE CHOLESTATIC | 3 0.03 57.96 JAW DISORDER | 1 0.01 57.97 JAW LESION EXCISION | 1 0.01 57.98 JOINT CREPITATION | 1 0.01 57.99 JOINT DISLOCATION | 4 0.04 58.03 JOINT INJURY | 3 0.03 58.06 JOINT RANGE OF MOTION DECREASED | 2 0.02 58.08 JOINT SPRAIN | 2 0.02 58.10 JOINT STIFFNESS | 1 0.01 58.11 JOINT SWELLING | 9 0.09 58.20 JUDGEMENT IMPAIRED | 2 0.02 58.22 JUGULAR VEIN THROMBOSIS | 1 0.01 58.23 JUVENILE ARTHRITIS | 1 0.01 58.24 KELOID SCAR | 1 0.01 58.25 KERATITIS BACTERIAL | 1 0.01 58.26 KERATITIS VIRAL | 1 0.01 58.27 KETOACIDOSIS | 4 0.04 58.31 KETONURIA | 1 0.01 58.32 KIDNEY FIBROSIS | 1 0.01 58.33 KIDNEY SMALL | 1 0.01 58.34 KIDNEY TRANSPLANT REJECTION | 4 0.04 58.38 KLEBSIELLA INFECTION | 3 0.03 58.41 KLEBSIELLA SEPSIS | 2 0.02 58.43 KNEE ARTHROPLASTY | 7 0.07 58.50 KNEE OPERATION | 1 0.01 58.51 LABILE BLOOD PRESSURE | 1 0.01 58.52 LABILE HYPERTENSION | 1 0.01 58.53 LABORATORY TEST ABNORMAL | 2 0.02 58.55 LABORATORY TEST INTERFERENCE | 1 0.01 58.56 LACERATION | 2 0.02 58.58 LACRIMATION INCREASED | 4 0.04 58.62 LAPAROSCOPY | 1 0.01 58.63 LARGE INTESTINAL OBSTRUCTION | 1 0.01 58.64 LARYNGEAL OEDEMA | 2 0.02 58.66 LARYNGITIS | 3 0.03 58.69 LARYNGOSPASM | 1 0.01 58.70 LARYNGOTRACHEAL OEDEMA | 1 0.01 58.71 LEFT VENTRICULAR FAILURE | 1 0.01 58.72 LEG AMPUTATION | 3 0.03 58.75 LEIOMYOMA | 1 0.01 58.76 LESION OF SCIATIC NERVE | 1 0.01 58.77 LETHARGY | 17 0.17 58.94 LEUKAEMIA | 1 0.01 58.95 LEUKOCYTOCLASTIC VASCULITIS | 2 0.02 58.97 LEUKOCYTOSIS | 4 0.04 59.01 LEUKOENCEPHALOPATHY | 4 0.04 59.05 LEUKOPENIA | 20 0.20 59.25 LIBIDO DECREASED | 3 0.03 59.28 LIBIDO DISORDER | 1 0.01 59.29 LIFE SUPPORT | 1 0.01 59.30 LIGAMENT RUPTURE | 1 0.01 59.31 LIGHT CHAIN ANALYSIS INCREASED | 1 0.01 59.32 LIMB DISCOMFORT | 1 0.01 59.33 LIMB INJURY | 4 0.04 59.37 LIMB MALFORMATION | 1 0.01 59.38 LINEAR IGA DISEASE | 2 0.02 59.40 LIP BLISTER | 1 0.01 59.41 LIP PAIN | 1 0.01 59.42 LIPASE INCREASED | 1 0.01 59.43 LIPIDS INCREASED | 1 0.01 59.44 LIPOATROPHY | 1 0.01 59.45 LIPODYSTROPHY ACQUIRED | 1 0.01 59.46 LIPOMA | 2 0.02 59.48 LIPOMATOSIS | 1 0.01 59.49 LIVEDO RETICULARIS | 1 0.01 59.50 LIVER ABSCESS | 3 0.03 59.53 LIVER DISORDER | 17 0.17 59.70 LIVER FUNCTION TEST ABNORMAL | 10 0.10 59.80 LIVER TRANSPLANT | 1 0.01 59.81 LIVER TRANSPLANT REJECTION | 1 0.01 59.82 LOBAR PNEUMONIA | 3 0.03 59.85 LOCAL ANAESTHESIA | 7 0.07 59.92 LOCAL SWELLING | 1 0.01 59.93 LOCALISED INFECTION | 1 0.01 59.94 LOCALISED OEDEMA | 1 0.01 59.95 LOCKED-IN SYNDROME | 1 0.01 59.96 LOGORRHOEA | 1 0.01 59.97 LONG QT SYNDROME | 2 0.02 59.99 LOSS OF CONSCIOUSNESS | 46 0.46 60.45 LOSS OF CONTROL OF LEGS | 1 0.01 60.46 LOWER EXTREMITY MASS | 1 0.01 60.47 LOWER GASTROINTESTINAL HAEMORRHAGE | 2 0.02 60.49 LOWER LIMB FRACTURE | 2 0.02 60.51 LOWER MOTOR NEURONE LESION | 1 0.01 60.52 LUMBAR SPINAL STENOSIS | 2 0.02 60.54 LUMBOSACRAL PLEXUS LESION | 1 0.01 60.55 LUNG DISORDER | 7 0.07 60.62 LUNG INFECTION | 3 0.03 60.65 LUNG INFECTION PSEUDOMONAL | 1 0.01 60.66 LUNG INFILTRATION | 11 0.11 60.77 LUNG INJURY | 1 0.01 60.78 LUNG NEOPLASM | 1 0.01 60.79 LUNG NEOPLASM MALIGNANT | 9 0.09 60.88 LUNG OPERATION | 1 0.01 60.89 LUPUS-LIKE SYNDROME | 5 0.05 60.94 LYMPHADENOPATHY | 6 0.06 61.00 LYMPHADENOPATHY MEDIASTINAL | 1 0.01 61.01 LYMPHANGIOSIS CARCINOMATOSA | 2 0.02 61.03 LYMPHATIC SYSTEM NEOPLASM | 1 0.01 61.04 LYMPHOCYTE COUNT DECREASED | 3 0.03 61.07 LYMPHOCYTE COUNT INCREASED | 3 0.03 61.10 LYMPHOCYTE PERCENTAGE DECREASED | 1 0.01 61.11 LYMPHOCYTE STIMULATION TEST POSITIVE | 1 0.01 61.12 LYMPHOCYTIC INFILTRATION | 1 0.01 61.13 LYMPHOCYTIC LEUKAEMIA | 1 0.01 61.14 LYMPHOCYTOSIS | 2 0.02 61.16 LYMPHOMA | 3 0.03 61.19 LYMPHOPENIA | 2 0.02 61.21 MACULAR DEGENERATION | 4 0.04 61.25 MACULAR OEDEMA | 5 0.05 61.30 MACULOPATHY | 1 0.01 61.31 MADAROSIS | 1 0.01 61.32 MAJOR DEPRESSION | 2 0.02 61.34 MALABSORPTION | 1 0.01 61.35 MALAISE | 34 0.34 61.69 MALIGNANT MELANOMA | 2 0.02 61.71 MALIGNANT NEOPLASM PROGRESSION | 10 0.10 61.81 MALLORY-WEISS SYNDROME | 1 0.01 61.82 MALNUTRITION | 1 0.01 61.83 MANIA | 8 0.08 61.91 MARITAL PROBLEM | 1 0.01 61.92 MASKED FACIES | 1 0.01 61.93 MASS | 1 0.01 61.94 MASTICATION DISORDER | 1 0.01 61.95 MASTOCYTOSIS | 1 0.01 61.96 MASTOIDITIS | 1 0.01 61.97 MEDICAL DEVICE COMPLICATION | 1 0.01 61.98 MEDICATION ERROR | 5 0.05 62.03 MEIBOMIAN GLAND DISCHARGE | 1 0.01 62.04 MELAENA | 7 0.07 62.11 MEMORY IMPAIRMENT | 9 0.09 62.20 MENINGEAL DISORDER | 1 0.01 62.21 MENINGIOMA | 1 0.01 62.22 MENINGITIS | 1 0.01 62.23 MENINGITIS ASEPTIC | 1 0.01 62.24 MENISCUS LESION | 2 0.02 62.26 MENOPAUSE | 2 0.02 62.28 MENORRHAGIA | 2 0.02 62.30 MENSTRUAL DISORDER | 1 0.01 62.31 MENSTRUATION IRREGULAR | 2 0.02 62.33 MENTAL DISORDER | 12 0.12 62.45 MENTAL DISORDER DUE TO A GENERAL MEDI.. | 1 0.01 62.46 MENTAL IMPAIRMENT | 3 0.03 62.49 MENTAL STATUS CHANGES | 13 0.13 62.62 MESENTERIC VEIN THROMBOSIS | 1 0.01 62.63 METABOLIC ACIDOSIS | 6 0.06 62.69 METABOLIC ALKALOSIS | 1 0.01 62.70 METABOLIC ENCEPHALOPATHY | 2 0.02 62.72 METASTASES TO BONE | 1 0.01 62.73 METASTASES TO CENTRAL NERVOUS SYSTEM | 1 0.01 62.74 METASTASES TO LIVER | 2 0.02 62.76 METASTASES TO LUNG | 2 0.02 62.78 METASTASES TO LYMPH NODES | 3 0.03 62.81 METASTASES TO NECK | 1 0.01 62.82 METASTATIC CARCINOMA OF THE BLADDER | 1 0.01 62.83 METHICILLIN-RESISTANT STAPHYLOCOCCAL .. | 2 0.02 62.85 METRORRHAGIA | 1 0.01 62.86 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA | 1 0.01 62.87 MICROANGIOPATHY | 1 0.01 62.88 MICROSPORUM INFECTION | 1 0.01 62.89 MICTURITION DISORDER | 2 0.02 62.91 MICTURITION URGENCY | 1 0.01 62.92 MIGRAINE | 7 0.07 62.99 MIGRAINE WITHOUT AURA | 1 0.01 63.00 MIOSIS | 12 0.12 63.12 MITOCHONDRIAL CYTOPATHY | 1 0.01 63.13 MITRAL VALVE CALCIFICATION | 2 0.02 63.15 MITRAL VALVE DISEASE | 1 0.01 63.16 MITRAL VALVE INCOMPETENCE | 10 0.10 63.26 MOANING | 2 0.02 63.28 MOBILITY DECREASED | 3 0.03 63.31 MONARTHRITIS | 1 0.01 63.32 MONOCYTE COUNT DECREASED | 1 0.01 63.33 MONOCYTE COUNT INCREASED | 2 0.02 63.35 MONOCYTE PERCENTAGE INCREASED | 1 0.01 63.36 MONONEURITIS | 1 0.01 63.37 MONONEUROPATHY MULTIPLEX | 1 0.01 63.38 MONOPARESIS | 1 0.01 63.39 MONOPLEGIA | 2 0.02 63.41 MOOD ALTERED | 1 0.01 63.42 MOOD DISORDER DUE TO A GENERAL MEDICA.. | 1 0.01 63.43 MOOD SWINGS | 3 0.03 63.46 MORGANELLA INFECTION | 1 0.01 63.47 MOTOR DYSFUNCTION | 2 0.02 63.49 MOTOR NEURONE DISEASE | 1 0.01 63.50 MOUTH HAEMORRHAGE | 1 0.01 63.51 MOUTH ULCERATION | 5 0.05 63.56 MOVEMENT DISORDER | 2 0.02 63.58 MUCORMYCOSIS | 1 0.01 63.59 MUCOSAL HAEMORRHAGE | 2 0.02 63.61 MUCOSAL INFLAMMATION | 4 0.04 63.65 MUCOUS MEMBRANE DISORDER | 1 0.01 63.66 MULTI-ORGAN DISORDER | 5 0.05 63.71 MULTI-ORGAN FAILURE | 13 0.13 63.84 MULTIPLE ALLERGIES | 1 0.01 63.85 MULTIPLE CHEMICAL SENSITIVITY | 1 0.01 63.86 MULTIPLE DRUG OVERDOSE | 72 0.72 64.58 MULTIPLE SCLEROSIS | 7 0.07 64.65 MULTIPLE SCLEROSIS RELAPSE | 2 0.02 64.67 MULTIPLE-DRUG RESISTANCE | 1 0.01 64.68 MUSCLE ATROPHY | 2 0.02 64.70 MUSCLE CONTRACTIONS INVOLUNTARY | 1 0.01 64.71 MUSCLE DISORDER | 2 0.02 64.73 MUSCLE FATIGUE | 1 0.01 64.74 MUSCLE INJURY | 1 0.01 64.75 MUSCLE NECROSIS | 1 0.01 64.76 MUSCLE RIGIDITY | 1 0.01 64.77 MUSCLE RUPTURE | 1 0.01 64.78 MUSCLE SPASMS | 31 0.31 65.09 MUSCLE SPASTICITY | 3 0.03 65.12 MUSCLE SWELLING | 1 0.01 65.13 MUSCLE TIGHTNESS | 2 0.02 65.15 MUSCLE TWITCHING | 6 0.06 65.21 MUSCULAR WEAKNESS | 10 0.10 65.31 MUSCULOSKELETAL CHEST PAIN | 2 0.02 65.33 MUSCULOSKELETAL DISORDER | 2 0.02 65.35 MUSCULOSKELETAL PAIN | 1 0.01 65.36 MUSCULOSKELETAL STIFFNESS | 5 0.05 65.41 MUTISM | 1 0.01 65.42 MYALGIA | 32 0.32 65.74 MYASTHENIA GRAVIS | 1 0.01 65.75 MYASTHENIC SYNDROME | 2 0.02 65.77 MYCOBACTERIAL INFECTION | 1 0.01 65.78 MYCOBACTERIUM AVIUM COMPLEX INFECTION | 3 0.03 65.81 MYCOSIS FUNGOIDES | 1 0.01 65.82 MYDRIASIS | 6 0.06 65.88 MYELITIS | 1 0.01 65.89 MYELITIS TRANSVERSE | 1 0.01 65.90 MYELODYSPLASTIC SYNDROME | 2 0.02 65.92 MYELOFIBROSIS | 2 0.02 65.94 MYELOPATHY | 1 0.01 65.95 MYOCARDIAC ABSCESS | 1 0.01 65.96 MYOCARDIAL FIBROSIS | 1 0.01 65.97 MYOCARDIAL INFARCTION | 225 2.25 68.22 MYOCARDIAL ISCHAEMIA | 3 0.03 68.25 MYOCARDITIS | 2 0.02 68.27 MYOCLONIC EPILEPSY | 1 0.01 68.28 MYOCLONUS | 3 0.03 68.31 MYOFASCIAL PAIN SYNDROME | 2 0.02 68.33 MYOPATHY | 1 0.01 68.34 MYOPATHY STEROID | 1 0.01 68.35 MYOPIA | 1 0.01 68.36 MYOSITIS | 5 0.05 68.41 MYOSITIS-LIKE SYNDROME | 1 0.01 68.42 NAIL DISCOLOURATION | 1 0.01 68.43 NAIL DISORDER | 1 0.01 68.44 NASAL SEPTUM PERFORATION | 1 0.01 68.45 NASOPHARYNGITIS | 4 0.04 68.49 NAUSEA | 78 0.78 69.27 NECK DEFORMITY | 1 0.01 69.28 NECK INJURY | 1 0.01 69.29 NECK PAIN | 16 0.16 69.45 NECROSIS | 1 0.01 69.46 NECROTISING FASCIITIS | 1 0.01 69.47 NECROTISING ULCERATIVE GINGIVOSTOMATI.. | 1 0.01 69.48 NEGATIVISM | 1 0.01 69.49 NEONATAL DISORDER | 4 0.04 69.53 NEOPLASM | 1 0.01 69.54 NEOPLASM MALIGNANT | 5 0.05 69.59 NEOPLASM PROGRESSION | 2 0.02 69.61 NEOPLASM PROSTATE | 1 0.01 69.62 NEOPLASM RECURRENCE | 1 0.01 69.63 NEPHRITIS ALLERGIC | 1 0.01 69.64 NEPHRITIS AUTOIMMUNE | 1 0.01 69.65 NEPHRITIS INTERSTITIAL | 10 0.10 69.75 NEPHROCALCINOSIS | 1 0.01 69.76 NEPHROLITHIASIS | 7 0.07 69.83 NEPHROPATHY TOXIC | 2 0.02 69.85 NEPHROTIC SYNDROME | 2 0.02 69.87 NERVE COMPRESSION | 1 0.01 69.88 NERVE INJURY | 5 0.05 69.93 NERVE ROOT LESION | 1 0.01 69.94 NERVOUS SYSTEM DISORDER | 7 0.07 70.01 NERVOUSNESS | 14 0.14 70.15 NEURODERMATITIS | 1 0.01 70.16 NEUROFIBROMA | 1 0.01 70.17 NEUROFIBROMATOSIS | 1 0.01 70.18 NEUROLOGICAL EXAMINATION ABNORMAL | 1 0.01 70.19 NEUROMYOPATHY | 2 0.02 70.21 NEUROPATHY | 1 0.01 70.22 NEUROPATHY PERIPHERAL | 6 0.06 70.28 NEUTROPENIA | 19 0.19 70.47 NEUTROPENIC SEPSIS | 2 0.02 70.49 NEUTROPHIL COUNT DECREASED | 10 0.10 70.59 NEUTROPHIL COUNT INCREASED | 2 0.02 70.61 NEUTROPHIL PERCENTAGE DECREASED | 2 0.02 70.63 NEUTROPHIL PERCENTAGE INCREASED | 1 0.01 70.64 NEUTROPHILIA | 1 0.01 70.65 NIGHT BLINDNESS | 1 0.01 70.66 NIGHT SWEATS | 7 0.07 70.73 NIGHTMARE | 4 0.04 70.77 NIKOLSKY'S SIGN | 1 0.01 70.78 NO ADVERSE DRUG EFFECT | 1 0.01 70.79 NO ADVERSE EFFECT | 2 0.02 70.81 NO THERAPEUTIC RESPONSE | 1 0.01 70.82 NOCARDIOSIS | 1 0.01 70.83 NOCTURIA | 3 0.03 70.86 NODAL RHYTHM | 1 0.01 70.87 NODULE | 1 0.01 70.88 NON-HODGKIN'S LYMPHOMA | 3 0.03 70.91 NONSPECIFIC REACTION | 2 0.02 70.93 NORMETANEPHRINE URINE INCREASED | 1 0.01 70.94 NUCLEAR MAGNETIC RESONANCE IMAGING BR.. | 3 0.03 70.97 NYSTAGMUS | 1 0.01 70.98 OBESITY | 4 0.04 71.02 OBSESSIVE-COMPULSIVE DISORDER | 2 0.02 71.04 OBSTRUCTION | 1 0.01 71.05 OBSTRUCTIVE AIRWAYS DISORDER | 2 0.02 71.07 OBSTRUCTIVE UROPATHY | 1 0.01 71.08 OCCULT BLOOD POSITIVE | 2 0.02 71.10 OCULAR HYPERAEMIA | 1 0.01 71.11 OCULAR ICTERUS | 1 0.01 71.12 OCULAR RETROBULBAR HAEMORRHAGE | 1 0.01 71.13 OCULAR VASCULAR DISORDER | 2 0.02 71.15 OCULOMUCOCUTANEOUS SYNDROME | 1 0.01 71.16 ODYNOPHAGIA | 2 0.02 71.18 OEDEMA | 11 0.11 71.29 OEDEMA MOUTH | 3 0.03 71.32 OEDEMA PERIPHERAL | 42 0.42 71.74 OEDEMATOUS PANCREATITIS | 1 0.01 71.75 OESOPHAGEAL CANDIDIASIS | 1 0.01 71.76 OESOPHAGEAL DISORDER | 2 0.02 71.78 OESOPHAGEAL OBSTRUCTION | 1 0.01 71.79 OESOPHAGEAL SPASM | 2 0.02 71.81 OESOPHAGEAL ULCER | 3 0.03 71.84 OESOPHAGITIS | 8 0.08 71.92 OESTROGEN RECEPTOR ASSAY POSITIVE | 1 0.01 71.93 OFF LABEL USE | 2 0.02 71.95 OLIGOHYDRAMNIOS | 1 0.01 71.96 OLIGOMENORRHOEA | 1 0.01 71.97 OMPHALITIS | 1 0.01 71.98 ONYCHOLYSIS | 1 0.01 71.99 OOPHORECTOMY | 1 0.01 72.00 OPEN WOUND | 1 0.01 72.01 OPPORTUNISTIC INFECTION | 2 0.02 72.03 OPTIC ATROPHY | 1 0.01 72.04 OPTIC ISCHAEMIC NEUROPATHY | 3 0.03 72.07 ORAL CANDIDIASIS | 1 0.01 72.08 ORAL DISCOMFORT | 2 0.02 72.10 ORAL FUNGAL INFECTION | 1 0.01 72.11 ORAL INFECTION | 1 0.01 72.12 ORAL INTAKE REDUCED | 12 0.12 72.24 ORAL MUCOSAL BLISTERING | 1 0.01 72.25 ORAL MUCOSAL PETECHIAE | 1 0.01 72.26 ORAL PAIN | 7 0.07 72.33 ORAL PUSTULE | 1 0.01 72.34 ORAL SOFT TISSUE DISORDER | 1 0.01 72.35 ORAL SURGERY | 2 0.02 72.37 ORGAN FAILURE | 1 0.01 72.38 ORTHOPNOEA | 2 0.02 72.40 ORTHOSTATIC HYPOTENSION | 3 0.03 72.43 OSTEITIS | 2 0.02 72.45 OSTEOARTHRITIS | 5 0.05 72.50 OSTEOLYSIS | 1 0.01 72.51 OSTEOMYELITIS | 15 0.15 72.66 OSTEOMYELITIS CHRONIC | 1 0.01 72.67 OSTEONECROSIS | 57 0.57 73.24 OSTEOPOROSIS | 6 0.06 73.30 OSTEOPOROTIC FRACTURE | 1 0.01 73.31 OTITIS MEDIA | 1 0.01 73.32 OTORHINOLARYNGOLOGICAL SURGERY | 1 0.01 73.33 OTORRHOEA | 1 0.01 73.34 OVARIAN CANCER | 1 0.01 73.35 OVARIAN ENLARGEMENT | 1 0.01 73.36 OVARIAN FIBROSIS | 1 0.01 73.37 OVERDOSE | 77 0.77 74.14 OXYGEN SATURATION ABNORMAL | 1 0.01 74.15 OXYGEN SATURATION DECREASED | 13 0.13 74.28 PAIN | 42 0.42 74.70 PAIN IN EXTREMITY | 34 0.34 75.04 PAIN IN JAW | 8 0.08 75.12 PAIN OF SKIN | 2 0.02 75.14 PAINFUL ERECTION | 1 0.01 75.15 PALATAL DISORDER | 1 0.01 75.16 PALLOR | 5 0.05 75.21 PALPITATIONS | 18 0.18 75.39 PANCREATIC CYST | 1 0.01 75.40 PANCREATIC ENZYMES INCREASED | 1 0.01 75.41 PANCREATIC NEOPLASM | 1 0.01 75.42 PANCREATITIS | 7 0.07 75.49 PANCREATITIS ACUTE | 7 0.07 75.56 PANCYTOPENIA | 24 0.24 75.80 PANIC ATTACK | 9 0.09 75.89 PANIC DISORDER | 1 0.01 75.90 PANNICULITIS | 1 0.01 75.91 PAPILLOEDEMA | 4 0.04 75.95 PAPILLOMA | 1 0.01 75.96 PARAESTHESIA | 19 0.19 76.15 PARAESTHESIA ORAL | 3 0.03 76.18 PARALYSIS | 6 0.06 76.24 PARANEOPLASTIC SYNDROME | 2 0.02 76.26 PARANOIA | 6 0.06 76.32 PARAPLEGIA | 6 0.06 76.38 PARESIS | 1 0.01 76.39 PARKINSON'S DISEASE | 2 0.02 76.41 PARKINSONISM | 1 0.01 76.42 PAROSMIA | 1 0.01 76.43 PATHOLOGICAL FRACTURE | 1 0.01 76.44 PCO2 DECREASED | 2 0.02 76.46 PCO2 INCREASED | 2 0.02 76.48 PELVIC ABSCESS | 1 0.01 76.49 PELVIC FIBROSIS | 1 0.01 76.50 PELVIC FRACTURE | 2 0.02 76.52 PEMPHIGOID | 2 0.02 76.54 PENILE HAEMORRHAGE | 1 0.01 76.55 PENILE PAIN | 1 0.01 76.56 PENIS DISORDER | 1 0.01 76.57 PEPTIC ULCER HAEMORRHAGE | 1 0.01 76.58 PERFORMANCE STATUS DECREASED | 1 0.01 76.59 PERICARDIAL EFFUSION | 2 0.02 76.61 PERICARDIAL HAEMORRHAGE | 1 0.01 76.62 PERICARDIAL RUB | 1 0.01 76.63 PERICARDITIS | 2 0.02 76.65 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE | 1 0.01 76.66 PERIPHERAL COLDNESS | 4 0.04 76.70 PERIPHERAL SENSORY NEUROPATHY | 1 0.01 76.71 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED | 2 0.02 76.73 PERIPHERAL VASCULAR DISORDER | 5 0.05 76.78 PERITONEAL DIALYSIS | 1 0.01 76.79 PERITONEAL EFFUSION | 1 0.01 76.80 PERITONITIS | 1 0.01 76.81 PERITONITIS BACTERIAL | 2 0.02 76.83 PERONEAL MUSCULAR ATROPHY | 1 0.01 76.84 PERONEAL NERVE PALSY | 4 0.04 76.88 PERSONALITY CHANGE | 3 0.03 76.91 PERSONALITY CHANGE DUE TO A GENERAL M.. | 1 0.01 76.92 PERSONALITY DISORDER | 1 0.01 76.93 PETECHIAE | 9 0.09 77.02 PETIT MAL EPILEPSY | 3 0.03 77.05 PHAEOCHROMOCYTOMA | 1 0.01 77.06 PHANTOM PAIN | 1 0.01 77.07 PHARMACEUTICAL PRODUCT COMPLAINT | 33 0.33 77.40 PHARMACEUTICAL PRODUCT COUNTERFEIT | 1 0.01 77.41 PHARYNGEAL OEDEMA | 2 0.02 77.43 PHARYNGITIS | 3 0.03 77.46 PHARYNGOLARYNGEAL PAIN | 13 0.13 77.59 PHARYNX DISCOMFORT | 1 0.01 77.60 PHLEBITIS DEEP | 1 0.01 77.61 PHOTOPHOBIA | 1 0.01 77.62 PHOTOPSIA | 1 0.01 77.63 PHOTOSENSITIVITY REACTION | 3 0.03 77.66 PHYSICAL ASSAULT | 1 0.01 77.67 PIERRE ROBIN SYNDROME | 1 0.01 77.68 PIGMENTATION DISORDER | 3 0.03 77.71 PITUITARY TUMOUR | 1 0.01 77.72 PLACENTAL INSUFFICIENCY | 1 0.01 77.73 PLASTIC SURGERY | 1 0.01 77.74 PLATELET COUNT DECREASED | 26 0.26 78.00 PLATELET COUNT INCREASED | 3 0.03 78.03 PLATELET DISORDER | 1 0.01 78.04 PLEURAL DISORDER | 1 0.01 78.05 PLEURAL EFFUSION | 12 0.12 78.17 PLEURAL FIBROSIS | 1 0.01 78.18 PLEURAL INFECTION | 1 0.01 78.19 PLEURISY | 2 0.02 78.21 PLEURITIC PAIN | 2 0.02 78.23 PNEUMATOSIS | 1 0.01 78.24 PNEUMATOSIS INTESTINALIS | 1 0.01 78.25 PNEUMOCEPHALUS | 1 0.01 78.26 PNEUMOCONIOSIS | 1 0.01 78.27 PNEUMOCYSTIS JIROVECI INFECTION | 1 0.01 78.28 PNEUMOCYSTIS JIROVECI PNEUMONIA | 4 0.04 78.32 PNEUMOMEDIASTINUM | 2 0.02 78.34 PNEUMONIA | 48 0.48 78.82 PNEUMONIA ASPERGILLUS | 1 0.01 78.83 PNEUMONIA ASPIRATION | 8 0.08 78.91 PNEUMONIA BACTERIAL | 1 0.01 78.92 PNEUMONIA FUNGAL | 1 0.01 78.93 PNEUMONIA LEGIONELLA | 1 0.01 78.94 PNEUMONIA MYCOPLASMAL | 1 0.01 78.95 PNEUMONIA PRIMARY ATYPICAL | 1 0.01 78.96 PNEUMONIA STAPHYLOCOCCAL | 2 0.02 78.98 PNEUMONIA VIRAL | 1 0.01 78.99 PNEUMONITIS | 3 0.03 79.02 PNEUMOTHORAX | 6 0.06 79.08 PO2 ABNORMAL | 2 0.02 79.10 PO2 DECREASED | 2 0.02 79.12 PO2 INCREASED | 2 0.02 79.14 POISONING | 3 0.03 79.17 POLLAKIURIA | 3 0.03 79.20 POLYCHROMASIA | 1 0.01 79.21 POLYCYSTIC LIVER DISEASE | 1 0.01 79.22 POLYDACTYLY | 1 0.01 79.23 POLYDIPSIA | 3 0.03 79.26 POLYDIPSIA PSYCHOGENIC | 1 0.01 79.27 POLYHYDRAMNIOS | 1 0.01 79.28 POLYMYALGIA RHEUMATICA | 1 0.01 79.29 POLYNEUROPATHY | 4 0.04 79.33 POLYNEUROPATHY IDIOPATHIC PROGRESSIVE | 1 0.01 79.34 POLYP | 1 0.01 79.35 POLYSUBSTANCE ABUSE | 1 0.01 79.36 POLYTRAUMATISM | 30 0.30 79.66 POLYURIA | 4 0.04 79.70 POOR QUALITY DRUG ADMINISTERED | 2 0.02 79.72 POST PROCEDURAL COMPLICATION | 21 0.21 79.93 POST PROCEDURAL DIARRHOEA | 1 0.01 79.94 POST PROCEDURAL HAEMATOMA | 1 0.01 79.95 POST PROCEDURAL HAEMORRHAGE | 4 0.04 79.99 POST PROCEDURAL NAUSEA | 1 0.01 80.00 POST PROCEDURAL VOMITING | 1 0.01 80.01 POST-TRAUMATIC STRESS DISORDER | 1 0.01 80.02 POSTNASAL DRIP | 1 0.01 80.03 POSTOPERATIVE INFECTION | 5 0.05 80.08 POSTPARTUM DEPRESSION | 1 0.01 80.09 POSTRENAL FAILURE | 1 0.01 80.10 POSTURE ABNORMAL | 1 0.01 80.11 PREGNANCY | 4 0.04 80.15 PREGNANCY OF PARTNER | 2 0.02 80.17 PREMATURE BABY | 1 0.01 80.18 PREMATURE LABOUR | 3 0.03 80.21 PREMATURE MENOPAUSE | 1 0.01 80.22 PREMATURE RUPTURE OF MEMBRANES | 2 0.02 80.24 PRESCRIBED OVERDOSE | 4 0.04 80.28 PRESSURE OF SPEECH | 1 0.01 80.29 PRIMARY SEQUESTRUM | 3 0.03 80.32 PROCEDURAL COMPLICATION | 9 0.09 80.41 PROCEDURAL PAIN | 2 0.02 80.43 PROCTALGIA | 1 0.01 80.44 PROCTITIS | 1 0.01 80.45 PROCTITIS ULCERATIVE | 2 0.02 80.47 PRODUCTIVE COUGH | 5 0.05 80.52 PROSTATE CANCER | 1 0.01 80.53 PROSTATE CANCER STAGE II | 1 0.01 80.54 PROSTATIC SPECIFIC ANTIGEN INCREASED | 1 0.01 80.55 PROSTATITIS | 1 0.01 80.56 PROTEIN S DEFICIENCY | 1 0.01 80.57 PROTEIN TOTAL DECREASED | 2 0.02 80.59 PROTEIN TOTAL INCREASED | 1 0.01 80.60 PROTEIN URINE | 1 0.01 80.61 PROTEIN URINE PRESENT | 3 0.03 80.64 PROTEINURIA | 10 0.10 80.74 PROTEUS INFECTION | 1 0.01 80.75 PROTHROMBIN LEVEL INCREASED | 1 0.01 80.76 PROTHROMBIN TIME ABNORMAL | 1 0.01 80.77 PROTHROMBIN TIME PROLONGED | 2 0.02 80.79 PROTHROMBIN TIME RATIO DECREASED | 2 0.02 80.81 PROTHROMBIN TIME SHORTENED | 1 0.01 80.82 PRURITUS | 30 0.30 81.12 PSEUDARTHROSIS | 3 0.03 81.15 PSEUDOCYST | 1 0.01 81.16 PSEUDOMONAL SEPSIS | 1 0.01 81.17 PSEUDOMONAS INFECTION | 4 0.04 81.21 PSORIASIS | 3 0.03 81.24 PSYCHIATRIC SYMPTOM | 1 0.01 81.25 PSYCHOGENIC PAIN DISORDER | 1 0.01 81.26 PSYCHOMOTOR HYPERACTIVITY | 4 0.04 81.30 PSYCHOSOMATIC DISEASE | 1 0.01 81.31 PSYCHOTIC DISORDER | 11 0.11 81.42 PULMONARY CAVITATION | 1 0.01 81.43 PULMONARY CONGESTION | 8 0.08 81.51 PULMONARY EMBOLISM | 31 0.31 81.82 PULMONARY FIBROSIS | 5 0.05 81.87 PULMONARY FUNCTION TEST ABNORMAL | 2 0.02 81.89 PULMONARY FUNCTION TEST DECREASED | 1 0.01 81.90 PULMONARY GRANULOMA | 2 0.02 81.92 PULMONARY HAEMATOMA | 1 0.01 81.93 PULMONARY HYPERTENSION | 4 0.04 81.97 PULMONARY INFARCTION | 1 0.01 81.98 PULMONARY OEDEMA | 13 0.13 82.11 PULMONARY THROMBOSIS | 2 0.02 82.13 PULMONARY TOXICITY | 4 0.04 82.17 PULMONARY TUBERCULOSIS | 4 0.04 82.21 PULMONARY VALVE DISEASE | 1 0.01 82.22 PULMONARY VASCULAR DISORDER | 1 0.01 82.23 PULSE ABNORMAL | 1 0.01 82.24 PULSE ABSENT | 2 0.02 82.26 PUNCTURE SITE REACTION | 1 0.01 82.27 PUPIL FIXED | 2 0.02 82.29 PUPILLARY DISORDER | 3 0.03 82.32 PUPILLARY REFLEX IMPAIRED | 1 0.01 82.33 PUPILS UNEQUAL | 3 0.03 82.36 PURPURA | 5 0.05 82.41 PURULENCE | 1 0.01 82.42 PURULENT DISCHARGE | 2 0.02 82.44 PUSTULAR PSORIASIS | 2 0.02 82.46 PYELONEPHRITIS | 3 0.03 82.49 PYREXIA | 85 0.85 83.34 QRS AXIS ABNORMAL | 1 0.01 83.35 QUADRUPLE VESSEL BYPASS GRAFT | 1 0.01 83.36 RADIAL NERVE PALSY | 1 0.01 83.37 RADIATION INJURY | 1 0.01 83.38 RADICULAR SYNDROME | 1 0.01 83.39 RADICULOPATHY | 1 0.01 83.40 RADIOTHERAPY | 1 0.01 83.41 RALES | 3 0.03 83.44 RASH | 30 0.30 83.74 RASH ERYTHEMATOUS | 14 0.14 83.88 RASH GENERALISED | 5 0.05 83.93 RASH MACULAR | 5 0.05 83.98 RASH MACULO-PAPULAR | 6 0.06 84.04 RASH PAPULAR | 2 0.02 84.06 RASH PRURITIC | 9 0.09 84.15 RASH PUSTULAR | 2 0.02 84.17 REACTIVE PSYCHOSIS | 1 0.01 84.18 REBOUND EFFECT | 1 0.01 84.19 RECTAL ADENOMA | 1 0.01 84.20 RECTAL HAEMORRHAGE | 15 0.15 84.35 RECTAL TENESMUS | 1 0.01 84.36 RECTAL ULCER | 1 0.01 84.37 RECURRENT CANCER | 1 0.01 84.38 RED BLOOD CELL COUNT DECREASED | 12 0.12 84.50 RED BLOOD CELL SEDIMENTATION RATE INC.. | 3 0.03 84.53 RED BLOOD CELLS URINE | 1 0.01 84.54 RED CELL DISTRIBUTION WIDTH INCREASED | 2 0.02 84.56 REFLUX OESOPHAGITIS | 1 0.01 84.57 REFUSAL OF TREATMENT BY PATIENT | 3 0.03 84.60 REGURGITATION OF FOOD | 2 0.02 84.62 RENAL ARTERY THROMBOSIS | 1 0.01 84.63 RENAL CELL CARCINOMA STAGE UNSPECIFIED | 2 0.02 84.65 RENAL COLIC | 1 0.01 84.66 RENAL CYST | 4 0.04 84.70 RENAL DISORDER | 3 0.03 84.73 RENAL FAILURE | 30 0.30 85.03 RENAL FAILURE ACUTE | 33 0.33 85.36 RENAL FAILURE CHRONIC | 10 0.10 85.46 RENAL IMPAIRMENT | 10 0.10 85.56 RENAL TRANSPLANT | 1 0.01 85.57 RENAL TUBULAR ATROPHY | 1 0.01 85.58 RENAL TUBULAR DISORDER | 5 0.05 85.63 RENAL TUBULAR NECROSIS | 6 0.06 85.69 RENIN DECREASED | 1 0.01 85.70 RESPIRATION ABNORMAL | 3 0.03 85.73 RESPIRATORY ACIDOSIS | 2 0.02 85.75 RESPIRATORY ALKALOSIS | 1 0.01 85.76 RESPIRATORY ARREST | 7 0.07 85.83 RESPIRATORY DEPRESSION | 5 0.05 85.88 RESPIRATORY DISORDER | 5 0.05 85.93 RESPIRATORY DISTRESS | 5 0.05 85.98 RESPIRATORY FAILURE | 20 0.20 86.18 RESPIRATORY RATE DECREASED | 1 0.01 86.19 RESPIRATORY RATE INCREASED | 3 0.03 86.22 RESPIRATORY TRACT CONGESTION | 3 0.03 86.25 RESPIRATORY TRACT INFECTION | 1 0.01 86.26 RESTLESS LEGS SYNDROME | 2 0.02 86.28 RESTLESSNESS | 7 0.07 86.35 RESUSCITATION | 1 0.01 86.36 RETCHING | 2 0.02 86.38 RETICULOCYTE COUNT DECREASED | 1 0.01 86.39 RETICULOCYTOSIS | 2 0.02 86.41 RETINAL ARTERY OCCLUSION | 4 0.04 86.45 RETINAL ARTERY THROMBOSIS | 2 0.02 86.47 RETINAL DETACHMENT | 1 0.01 86.48 RETINAL EXUDATES | 1 0.01 86.49 RETINAL HAEMORRHAGE | 4 0.04 86.53 RETINAL PIGMENTATION | 1 0.01 86.54 RETINAL VASCULAR DISORDER | 1 0.01 86.55 RETINAL VASCULAR THROMBOSIS | 1 0.01 86.56 RETINAL VASCULITIS | 1 0.01 86.57 RETINAL VEIN OCCLUSION | 1 0.01 86.58 RETINOPATHY | 1 0.01 86.59 RETROPERITONEAL HAEMATOMA | 2 0.02 86.61 RETROPERITONEAL HAEMORRHAGE | 2 0.02 86.63 REVERSIBLE ISCHAEMIC NEUROLOGICAL DEF.. | 1 0.01 86.64 REYE'S SYNDROME | 1 0.01 86.65 RHABDOMYOLYSIS | 18 0.18 86.83 RHEUMATOID ARTHRITIS | 3 0.03 86.86 RHEUMATOID FACTOR POSITIVE | 1 0.01 86.87 RHINITIS | 1 0.01 86.88 RHINORRHOEA | 3 0.03 86.91 RHONCHI | 1 0.01 86.92 RIB DEFORMITY | 1 0.01 86.93 RIB FRACTURE | 2 0.02 86.95 RIGHT VENTRICULAR FAILURE | 2 0.02 86.97 ROAD TRAFFIC ACCIDENT | 8 0.08 87.05 ROSACEA | 1 0.01 87.06 ROTATOR CUFF SYNDROME | 1 0.01 87.07 SALIVARY GLAND DISORDER | 1 0.01 87.08 SALIVARY GLAND ENLARGEMENT | 1 0.01 87.09 SALIVARY HYPERSECRETION | 3 0.03 87.12 SALMONELLOSIS | 1 0.01 87.13 SARCOIDOSIS | 1 0.01 87.14 SARCOMA | 1 0.01 87.15 SCHISTOSOMIASIS | 1 0.01 87.16 SCHIZOAFFECTIVE DISORDER | 1 0.01 87.17 SCHIZOPHRENIA | 4 0.04 87.21 SCHIZOPHRENIFORM DISORDER | 1 0.01 87.22 SCIATICA | 1 0.01 87.23 SCLERITIS | 1 0.01 87.24 SCRATCH | 2 0.02 87.26 SCREAMING | 1 0.01 87.27 SEASONAL ALLERGY | 1 0.01 87.28 SEBORRHOEIC DERMATITIS | 2 0.02 87.30 SECONDARY SYPHILIS | 1 0.01 87.31 SECRETION DISCHARGE | 2 0.02 87.33 SEDATION | 6 0.06 87.39 SELF INJURIOUS BEHAVIOUR | 2 0.02 87.41 SELF MUTILATION | 2 0.02 87.43 SENSATION OF FOREIGN BODY | 4 0.04 87.47 SENSORY DISTURBANCE | 3 0.03 87.50 SEPSIS | 20 0.20 87.70 SEPTIC EMBOLUS | 1 0.01 87.71 SEPTIC SHOCK | 8 0.08 87.79 SEQUESTRECTOMY | 1 0.01 87.80 SEROTONIN SYNDROME | 2 0.02 87.82 SERUM FERRITIN INCREASED | 2 0.02 87.84 SERUM SEROTONIN DECREASED | 1 0.01 87.85 SERUM SEROTONIN INCREASED | 1 0.01 87.86 SEXUAL DYSFUNCTION | 1 0.01 87.87 SHOCK | 11 0.11 87.98 SHOCK HAEMORRHAGIC | 1 0.01 87.99 SHOULDER PAIN | 7 0.07 88.06 SICCA SYNDROME | 1 0.01 88.07 SIGMOIDITIS | 1 0.01 88.08 SILENT MYOCARDIAL INFARCTION | 1 0.01 88.09 SINUS BRADYCARDIA | 2 0.02 88.11 SINUS DISORDER | 1 0.01 88.12 SINUS HEADACHE | 2 0.02 88.14 SINUS OPERATION | 1 0.01 88.15 SINUS TACHYCARDIA | 5 0.05 88.20 SINUSITIS | 11 0.11 88.31 SINUSITIS FUNGAL | 1 0.01 88.32 SJOGREN'S SYNDROME | 3 0.03 88.35 SKIN ATROPHY | 2 0.02 88.37 SKIN CANCER | 3 0.03 88.40 SKIN CHAPPED | 2 0.02 88.42 SKIN DISCOLOURATION | 2 0.02 88.44 SKIN DISORDER | 6 0.06 88.50 SKIN EXFOLIATION | 5 0.05 88.55 SKIN FISSURES | 1 0.01 88.56 SKIN HAEMORRHAGE | 3 0.03 88.59 SKIN HYPERPIGMENTATION | 1 0.01 88.60 SKIN INFECTION | 1 0.01 88.61 SKIN LACERATION | 2 0.02 88.63 SKIN LESION | 6 0.06 88.69 SKIN NECROSIS | 3 0.03 88.72 SKIN ODOUR ABNORMAL | 1 0.01 88.73 SKIN OEDEMA | 1 0.01 88.74 SKIN PAPILLOMA | 1 0.01 88.75 SKIN REACTION | 1 0.01 88.76 SKIN SWELLING | 1 0.01 88.77 SKIN TIGHTNESS | 2 0.02 88.79 SKIN TOXICITY | 1 0.01 88.80 SKIN ULCER | 4 0.04 88.84 SLEEP APNOEA SYNDROME | 2 0.02 88.86 SLEEP DISORDER | 6 0.06 88.92 SLEEP TERROR | 2 0.02 88.94 SLUGGISHNESS | 1 0.01 88.95 SMALL CELL LUNG CANCER STAGE UNSPECIF.. | 1 0.01 88.96 SMALL INTESTINAL OBSTRUCTION | 1 0.01 88.97 SOCIAL AVOIDANT BEHAVIOUR | 1 0.01 88.98 SOCIAL PROBLEM | 1 0.01 88.99 SODIUM RETENTION | 1 0.01 89.00 SOFT TISSUE DISORDER | 2 0.02 89.02 SOFT TISSUE INJURY | 1 0.01 89.03 SOMNOLENCE | 49 0.49 89.52 SPEECH DISORDER | 17 0.17 89.69 SPERM COUNT DECREASED | 1 0.01 89.70 SPHEROCYTIC ANAEMIA | 1 0.01 89.71 SPINAL COMPRESSION FRACTURE | 2 0.02 89.73 SPINAL CORD HAEMORRHAGE | 1 0.01 89.74 SPINAL DISORDER | 1 0.01 89.75 SPINAL FRACTURE | 3 0.03 89.78 SPINAL OPERATION | 1 0.01 89.79 SPINAL OSTEOARTHRITIS | 3 0.03 89.82 SPINE MALFORMATION | 1 0.01 89.83 SPLEEN DISORDER | 1 0.01 89.84 SPLENECTOMY | 1 0.01 89.85 SPLENIC ABSCESS | 1 0.01 89.86 SPLENIC INFARCTION | 1 0.01 89.87 SPLENOMEGALY | 4 0.04 89.91 SPONDYLOLYSIS | 1 0.01 89.92 SPUTUM CULTURE POSITIVE | 3 0.03 89.95 SPUTUM DISCOLOURED | 2 0.02 89.97 SPUTUM RETENTION | 2 0.02 89.99 STAPHYLOCOCCAL BACTERAEMIA | 1 0.01 90.00 STAPHYLOCOCCAL INFECTION | 13 0.13 90.13 STARING | 1 0.01 90.14 STATUS ASTHMATICUS | 1 0.01 90.15 STATUS EPILEPTICUS | 3 0.03 90.18 STEM CELL TRANSPLANT | 2 0.02 90.20 STENOTROPHOMONAS INFECTION | 1 0.01 90.21 STENT PLACEMENT | 2 0.02 90.23 STERNAL FRACTURE | 1 0.01 90.24 STEVENS-JOHNSON SYNDROME | 2 0.02 90.26 STOMACH DISCOMFORT | 2 0.02 90.28 STOMATITIS | 4 0.04 90.32 STREPTOCOCCAL INFECTION | 1 0.01 90.33 STREPTOCOCCAL SEPSIS | 1 0.01 90.34 STRESS | 5 0.05 90.39 STRIDOR | 4 0.04 90.43 STUPOR | 3 0.03 90.46 SUBARACHNOID HAEMORRHAGE | 3 0.03 90.49 SUBCORNEAL PUSTULAR DERMATOSIS | 1 0.01 90.50 SUBCUTANEOUS EMPHYSEMA | 1 0.01 90.51 SUBCUTANEOUS HAEMATOMA | 2 0.02 90.53 SUBDURAL HAEMATOMA | 2 0.02 90.55 SUBDURAL HAEMORRHAGE | 1 0.01 90.56 SUBILEUS | 1 0.01 90.57 SUDDEN CARDIAC DEATH | 1 0.01 90.58 SUDDEN DEATH | 5 0.05 90.63 SUDDEN HEARING LOSS | 1 0.01 90.64 SUICIDAL IDEATION | 26 0.26 90.90 SUICIDE ATTEMPT | 17 0.17 91.07 SUNBURN | 1 0.01 91.08 SUPERINFECTION | 1 0.01 91.09 SUPRAVENTRICULAR EXTRASYSTOLES | 2 0.02 91.11 SUPRAVENTRICULAR TACHYCARDIA | 2 0.02 91.13 SURGERY | 8 0.08 91.21 SURGICAL PROCEDURE REPEATED | 1 0.01 91.22 SWEATING FEVER | 1 0.01 91.23 SWELLING | 7 0.07 91.30 SWELLING FACE | 10 0.10 91.40 SWOLLEN TONGUE | 6 0.06 91.46 SYNCOPE | 32 0.32 91.78 SYNCOPE VASOVAGAL | 1 0.01 91.79 SYNOVITIS | 3 0.03 91.82 SYSTEMIC CANDIDA | 2 0.02 91.84 SYSTEMIC LUPUS ERYTHEMATOSUS | 2 0.02 91.86 T-CELL LYMPHOMA | 1 0.01 91.87 TACHYARRHYTHMIA | 2 0.02 91.89 TACHYCARDIA | 12 0.12 92.01 TACHYCARDIA PAROXYSMAL | 1 0.01 92.02 TACHYPNOEA | 2 0.02 92.04 TAKAYASU'S ARTERITIS | 1 0.01 92.05 TARSAL TUNNEL SYNDROME | 1 0.01 92.06 TEARFULNESS | 2 0.02 92.08 TEMPERATURE INTOLERANCE | 1 0.01 92.09 TEMPERATURE REGULATION DISORDER | 2 0.02 92.11 TENDERNESS | 2 0.02 92.13 TENDON DISORDER | 5 0.05 92.18 TENDON RUPTURE | 2 0.02 92.20 TENDONITIS | 1 0.01 92.21 TENSION HEADACHE | 2 0.02 92.23 TERMINAL STATE | 1 0.01 92.24 TESTICULAR NEOPLASM | 1 0.01 92.25 TESTICULAR PAIN | 2 0.02 92.27 TESTIS CANCER | 1 0.01 92.28 THERAPEUTIC AGENT TOXICITY | 7 0.07 92.35 THERAPEUTIC PRODUCT INEFFECTIVE | 1 0.01 92.36 THERAPEUTIC RESPONSE DECREASED | 5 0.05 92.41 THERAPEUTIC RESPONSE UNEXPECTED | 4 0.04 92.45 THERAPEUTIC RESPONSE UNEXPECTED WITH .. | 3 0.03 92.48 THERAPY NON-RESPONDER | 8 0.08 92.56 THERMAL BURN | 7 0.07 92.63 THINKING ABNORMAL | 7 0.07 92.70 THIRST | 4 0.04 92.74 THORACIC VERTEBRAL FRACTURE | 1 0.01 92.75 THREAT OF REDUNDANCY | 1 0.01 92.76 THROAT IRRITATION | 3 0.03 92.79 THROAT TIGHTNESS | 5 0.05 92.84 THROMBOCYTOPENIA | 22 0.22 93.06 THROMBOCYTOPENIC PURPURA | 1 0.01 93.07 THROMBOPHLEBITIS | 1 0.01 93.08 THROMBOSIS | 74 0.74 93.82 THROMBOSIS IN DEVICE | 1 0.01 93.83 THROMBOTIC MICROANGIOPATHY | 1 0.01 93.84 THROMBOTIC STROKE | 1 0.01 93.85 THROMBOTIC THROMBOCYTOPENIC PURPURA | 2 0.02 93.87 THYROID ADENOMA | 1 0.01 93.88 THYROID DISORDER | 1 0.01 93.89 THYROID GLAND CANCER | 2 0.02 93.91 THYROID NEOPLASM | 3 0.03 93.94 THYROIDITIS | 1 0.01 93.95 THYROIDITIS SUBACUTE | 1 0.01 93.96 TIBIA FRACTURE | 1 0.01 93.97 TIC | 1 0.01 93.98 TINNITUS | 4 0.04 94.02 TOE AMPUTATION | 1 0.01 94.03 TONGUE ATROPHY | 1 0.01 94.04 TONGUE BITING | 1 0.01 94.05 TONGUE DRY | 1 0.01 94.06 TONGUE OEDEMA | 2 0.02 94.08 TONGUE ULCERATION | 1 0.01 94.09 TONSILLAR DISORDER | 1 0.01 94.10 TONSILLAR HYPERTROPHY | 1 0.01 94.11 TOOTH ABSCESS | 3 0.03 94.14 TOOTH DISCOLOURATION | 1 0.01 94.15 TOOTH DISORDER | 4 0.04 94.19 TOOTH EXTRACTION | 12 0.12 94.31 TOOTH LOSS | 2 0.02 94.33 TOOTHACHE | 3 0.03 94.36 TORSADE DE POINTES | 7 0.07 94.43 TOXIC EPIDERMAL NECROLYSIS | 1 0.01 94.44 TOXIC INDUCED ENCEPHALOPATHY | 2 0.02 94.46 TOXIC SHOCK SYNDROME | 1 0.01 94.47 TOXIC SKIN ERUPTION | 3 0.03 94.50 TOXICOLOGIC TEST ABNORMAL | 1 0.01 94.51 TRACHEOBRONCHITIS | 1 0.01 94.52 TRANSAMINASES INCREASED | 9 0.09 94.61 TRANSIENT ISCHAEMIC ATTACK | 16 0.16 94.77 TRANSMISSION OF DRUG VIA SEMEN | 1 0.01 94.78 TRANSPLANT FAILURE | 4 0.04 94.82 TREATMENT NONCOMPLIANCE | 21 0.21 95.03 TREATMENT RELATED SECONDARY MALIGNANCY | 1 0.01 95.04 TREMOR | 33 0.33 95.37 TRICHIASIS | 1 0.01 95.38 TRICUSPID VALVE INCOMPETENCE | 5 0.05 95.43 TRIGEMINAL NEURALGIA | 1 0.01 95.44 TRIPLE VESSEL BYPASS GRAFT | 1 0.01 95.45 TRISMUS | 1 0.01 95.46 TRISOMY 21 | 1 0.01 95.47 TROPONIN I INCREASED | 1 0.01 95.48 TUBERCULOSIS | 6 0.06 95.54 TUBULOINTERSTITIAL NEPHRITIS | 1 0.01 95.55 TUMOUR ASSOCIATED FEVER | 1 0.01 95.56 TUMOUR HAEMORRHAGE | 1 0.01 95.57 TUMOUR LYSIS SYNDROME | 1 0.01 95.58 TUMOUR NECROSIS | 1 0.01 95.59 TUNNEL VISION | 1 0.01 95.60 TYMPANIC MEMBRANE DISORDER | 2 0.02 95.62 ULCER | 5 0.05 95.67 ULCER HAEMORRHAGE | 1 0.01 95.68 ULNAR NERVE INJURY | 1 0.01 95.69 ULTRASOUND SCAN ABNORMAL | 1 0.01 95.70 UMBILICAL HERNIA | 1 0.01 95.71 UNEVALUABLE EVENT | 3 0.03 95.74 UNINTENDED PREGNANCY | 2 0.02 95.76 UNRESPONSIVE TO VERBAL STIMULI | 1 0.01 95.77 UPPER GASTROINTESTINAL HAEMORRHAGE | 2 0.02 95.79 UPPER LIMB FRACTURE | 2 0.02 95.81 UPPER MOTOR NEURONE LESION | 1 0.01 95.82 UPPER RESPIRATORY TRACT INFECTION | 1 0.01 95.83 URETERIC DILATATION | 1 0.01 95.84 URETERIC STENOSIS | 1 0.01 95.85 URETHRAL STENOSIS | 1 0.01 95.86 URETHRITIS | 1 0.01 95.87 URINARY BLADDER POLYP | 1 0.01 95.88 URINARY HESITATION | 2 0.02 95.90 URINARY INCONTINENCE | 3 0.03 95.93 URINARY RETENTION | 6 0.06 95.99 URINARY TRACT DISORDER | 1 0.01 96.00 URINARY TRACT INFECTION | 17 0.17 96.17 URINARY TRACT INFECTION ENTEROCOCCAL | 1 0.01 96.18 URINARY TRACT INFECTION FUNGAL | 1 0.01 96.19 URINARY TRACT INFECTION STAPHYLOCOCCAL | 1 0.01 96.20 URINE LEUKOCYTE ESTERASE POSITIVE | 1 0.01 96.21 URINE OUTPUT DECREASED | 3 0.03 96.24 URINE POTASSIUM DECREASED | 1 0.01 96.25 URINE SODIUM INCREASED | 1 0.01 96.26 URINE URIC ACID INCREASED | 1 0.01 96.27 UROSEPSIS | 2 0.02 96.29 URTICARIA | 18 0.18 96.47 URTICARIA GENERALISED | 2 0.02 96.49 URTICARIA PAPULAR | 1 0.01 96.50 UTERINE DISORDER | 1 0.01 96.51 UVEITIS | 2 0.02 96.53 VAGINAL CANCER STAGE II | 1 0.01 96.54 VAGINAL DISORDER | 1 0.01 96.55 VAGINAL HAEMORRHAGE | 4 0.04 96.59 VARICELLA | 1 0.01 96.60 VARICOSE VEIN | 1 0.01 96.61 VASCULAR INJURY | 5 0.05 96.66 VASCULAR OPERATION | 1 0.01 96.67 VASCULAR PSEUDOANEURYSM | 2 0.02 96.69 VASCULAR PURPURA | 3 0.03 96.72 VASCULITIS | 3 0.03 96.75 VASOCONSTRICTION | 1 0.01 96.76 VASODILATATION | 1 0.01 96.77 VATER SYNDROME | 1 0.01 96.78 VEIN DISORDER | 1 0.01 96.79 VENOOCCLUSIVE DISEASE | 1 0.01 96.80 VENOUS INJURY | 1 0.01 96.81 VENOUS OCCLUSION | 1 0.01 96.82 VENOUS THROMBOSIS | 1 0.01 96.83 VENOUS THROMBOSIS LIMB | 2 0.02 96.85 VENTRICULAR ARRHYTHMIA | 1 0.01 96.86 VENTRICULAR DYSFUNCTION | 1 0.01 96.87 VENTRICULAR EXTRASYSTOLES | 8 0.08 96.95 VENTRICULAR FIBRILLATION | 6 0.06 97.01 VENTRICULAR HYPERTROPHY | 10 0.10 97.11 VENTRICULAR SEPTAL DEFECT | 1 0.01 97.12 VENTRICULAR TACHYCARDIA | 4 0.04 97.16 VERTEBRAL ARTERY OCCLUSION | 1 0.01 97.17 VERTIGO | 14 0.14 97.31 VESTIBULAR DISORDER | 1 0.01 97.32 VIRAL INFECTION | 8 0.08 97.40 VIRAL MUTATION IDENTIFIED | 3 0.03 97.43 VISION BLURRED | 20 0.20 97.63 VISUAL ACUITY REDUCED | 17 0.17 97.80 VISUAL DISTURBANCE | 14 0.14 97.94 VISUAL EVOKED POTENTIALS ABNORMAL | 1 0.01 97.95 VISUAL FIELD DEFECT | 5 0.05 98.00 VITAL CAPACITY DECREASED | 1 0.01 98.01 VITREOUS DETACHMENT | 1 0.01 98.02 VITREOUS HAEMORRHAGE | 1 0.01 98.03 VITRITIS | 1 0.01 98.04 VOCAL CORD DISORDER | 1 0.01 98.05 VOCAL CORD PARALYSIS | 1 0.01 98.06 VOMITING | 74 0.74 98.80 VULVAL CANCER | 2 0.02 98.82 WEIGHT DECREASED | 32 0.32 99.14 WEIGHT FLUCTUATION | 2 0.02 99.16 WEIGHT INCREASED | 13 0.13 99.29 WHEEZING | 8 0.08 99.37 WHITE BLOOD CELL COUNT DECREASED | 22 0.22 99.59 WHITE BLOOD CELL COUNT INCREASED | 15 0.15 99.74 WOUND DEBRIDEMENT | 8 0.08 99.82 WOUND DEHISCENCE | 1 0.01 99.83 WOUND DRAINAGE | 2 0.02 99.85 WOUND INFECTION PSEUDOMONAS | 2 0.02 99.87 WOUND TREATMENT | 5 0.05 99.92 WRONG DRUG ADMINISTERED | 1 0.01 99.93 WRONG TECHNIQUE IN DRUG USAGE PROCESS | 3 0.03 99.96 XANTHELASMA | 1 0.01 99.97 XEROPHTHALMIA | 1 0.01 99.98 ZYGOMYCOSIS | 2 0.02 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015